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Summary 
Herpesviruses are large DNA viruses which have evolved in close association with their hosts 
over millions of years. Following primary infection, they persist in the form of latency posing 
the constant risk of reactivation and disease. Herpesviruses have developed a multitude of 
mechanisms to escape antiviral host mechanisms and reprogram cellular gene expression to 
support efficient virus replication, life-long maintenance (latency) as well as efficient 
reactivation thereof. Hence, herpesvirus infections are ideal models for studying key cellular 
mechanisms involved in the regulation of gene expression and innate and adaptive immunity.  
This thesis reports on transcriptional and post-transcriptional regulations of cellular and viral 
gene expression during lytic murine cytomegalovirus infection.  
 
Topic I 
Real-time transcriptional profiling of cellular and viral gene expression during lytic 
cytomegalovirus infection   
During lytic viral infection the cellular gene expression profile is subjected to dramatic 
changes induced by both viral and antiviral mechanisms. Many of these changes are only very 
transient and thus hard to dissect using standard gene expression analysis on total cellular 
RNA. We employed metabolic labelling of newly transcribed RNA using 4-thiouridine (4sU-
tagging) coupled to quantitative real-time PCR (qRT-PCR), microarray analysis and RNA-
Sequencing (RNA-Seq) to study the real-time kinetics of transcriptional activities during lytic 
murine cytomegalovirus (MCMV) infection. Microarray profiling on newly transcribed RNA 
during the first six hours of MCMV infection revealed discrete functional clusters of cellular 
genes regulated with distinct kinetics at surprising temporal resolution. Among others, this 
included a rapid inflammatory/interferon-response; a transient DNA-damage-response and a 
delayed endoplasmic reticulum (ER)-stress-response, which were all rapidly counter-
regulated by the virus, implying the involvement of novel viral regulators. It is important to 
note that most of these changes as well as their temporal order (the rapid counter-regulations 
in particular) were inherently undetectable by conventional total RNA purification. Promoter 
analysis revealed strong associations of distinct transcription factors with each functional 
cluster. Furthermore, metabolic labeling and purification of newly transcribed RNA provided 
access to the real-time kinetics of viral gene expression in the absence of any interfering 
virion-associated RNA. This revealed three surprising findings. First, both, qRT-PCR and 
RNA-Seq analysis on newly transcribed RNA derived from various time frames of the whole 
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lytic virus life cycle revealed a peak of viral transcriptional activity at 1-2 hours post infection 
(hpi), including transcription of immediate-early, early and even well characterized late genes. 
Second, this peak of transcription was subject to rapid gene silencing until the onset of DNA 
replication, indicating the involvement of so far undisclosed molecular mechanism in the 
regulation of viral gene expression. Finally, transcriptional activity of some viral genes 
remained remarkably constant or even declined substantially despite the rapid onset of viral 
DNA replication, highlighting the importance of transcription factor activity and chromatin 
status rather than DNA copy number in regulating viral gene expression. In summary, this 
study pioneers real-time transcriptional analysis during lytic herpesvirus infection and 
highlights numerous novel regulatory aspects of virus host-cell interaction. 
 
Topic II 
Degradation of cellular miR-27 by a novel, highly abundant viral transcript is important 
for efficient virus replication in vivo 
MicroRNAs (miRNAs) are small non-coding RNAs which regulate expression of various 
genes on post-transcriptional level. While the mechanism how miRNA repress transcription 
of their target genes is more and more understood, little is known about mechanisms how 
miRNA by themselves are regulated and degraded in particular. In this work we studied the 
mechanism behind rapid degradation of two cellular miRNAs, namely miR-27a/b, we 
observed during lytic MCMV infection. Using a set of virus deletion mutants, miR-27a and 
miR-27b were found to be targeted for degradation by a highly abundant viral protein-coding 
transcript with an additional non-coding RNA function, namely m169. This is mediated via a 
single miR-27 binding site in its 3’ untranslated region (UTR). This function could be 
efficiently retargeted to other cellular and viral miRNAs by miRNA target site replacement. 
Furthermore, the degradation of miR-27 was preceded by 3'-tailing and trimming as well as 
displacement of tailed miRNAs from Argonaute 2 complexes. Despite the rapid degradation 
of miR-27 by m169 we found this interaction to mutual resulting in miR-27-mediated 
repression of m169 protein expression. Most importantly, three mutant viruses which were no 
longer able to target miR-27a/b, either due to miRNA target site disruption or target site 
replacement, showed significant attenuation in multiple organs as early as 4 days post 
infection. This indicates that the miR-27/m169 interaction and degradation of miR-27a/b is 
important for efficient MCMV replication in vivo. In summary, these findings describe the 
degradation of two cellular miRNAs by an abundant viral transcript revealing a novel 
mechanism by which MCMV alters the host cell miRNA machinery for its own needs. 
Regulation of viral and cellular gene expression upon lytic murine cytomegalovirus infection  
 VIII 
Publications 
Part of this work has been published or is in the process of being published. 
 
Lisa Marcinowski
Real-time transcriptional profiling of cellular and viral gene expression during lytic 
cytomegalovirus infection.  
, Michael Lidschreiber, Lukas Windhager, Martina Rieder, Jens B. Bosse, 
Bernd Rädle, Thomas Bonfert, Ildiko Györy, Olivia Prazeres da Costa,  Philip Rosenstiel, 
Caroline C. Friedel, Ralf Zimmer, Zsolt Ruzsics, Lars Dölken  
Plos Pathogen (submitted) (2012). 
 
Lisa Marcinowski
Degradation of cellular miR-27 by a novel, highly abundant viral transcript is important 
for efficient virus replication in vivo.  
*, Mélanie Tanguy*, Astrid Krmpotic*, Bernd Rädle, Vanda J Lisnić, Lee 
Tuddenham, Béatrice Chane-Woon-Ming, Zsolt Ruzsics, Florian Erhard, Corinna Benkartek, 
Marina Babic, Ralf Zimmer, Joanne Trgovcich, Ulrich Koszinowski, Stipan Jonjic, Sébastien 
Pfeffer, Lars Dölken (2012).   
Plos Pathogen 8(2):e1002510. 
  
 
Further publications related to the thesis: 
 
Miller C, Schwalb B, Maier K, Schulz D, Dümcke S, Zacher B, Mayer A, Sydow 
J, Marcinowski L, Dölken L, Martin DE, Tresch A, Cramer P. 2011. Dynamic transcriptome 
analysis measures rates of mRNA synthesis and decay in yeast. Mol Syst Biol, 7:458 
 
Dölken L, Krmpotic A, Kothe S, Tuddenham L, Tanguy M, Marcinowski L, Ruzsics Z, 
Elefant N, Altuvia Y, Margalit H, Koszinowski UH, Jonjic S, Pfeffer S. 2010. 
Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS 
Pathogen, 6 (10) 
 
Dölken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G, Marcinowski L, Motsch N, 
Barth S, Beitzinger M, Lieber D, Bailer SM, Hoffmann R, Ruzsics Z, Kremmer E, Pfeffer S, 
Zimmer R, Koszinowski UH, Grässer F, Meister G, Haas J. 2010. Systematic analysis of viral 
and cellular microRNA targets in cells latently infected with human gamma-herpesvirus by 
RISC immunoprecipitation assay. Cell Host Microbe, 7 (4) 
 
Buck AH, Perot J, Chisholm MA, Kumar DS, Tuddenham L, Cognat V, Marcinowski L, 
Dölken L, Pfeffer S. 2010. Post-transcriptional regulation of miR-27 in murine 
cytomegalovirus infection.  
RNA, 16 (2) 
I        General Introduction  
 9 
General Introduction 
 
I.1 Cytomegalovirus 
 
Herpesviridae represent a family of large double-stranded DNA viruses which can be 
subdivided into alpha-, beta- and gamma-herpesvirinae based on biological properties, such as 
host range and length of reproductive cycle [1]. The human Cytomegalovirus (HCMV) is the 
best-studied member of the beta-herpesvirinae. Like all other herpesviruses, HCMV shares 
the ability to persist for life in the human host in latent form with the risk for reactivation and 
disease. While primary infection is usually asymptomatic, reactivation may result in life-
threatening disease in immunocompromised patients and for the fetus during pregnancy. Due 
to its broad cell tropism HCMV reactivation is able to affect almost every organ of the body 
with pneumonia, colitis, retinitis (in AIDS patients) and deafness (following congenital 
infection) being the most common clinical presentations (reviewed in [2]). 
 
I.1.1 Life cycle 
 
The lifecycle of CMV can be divided into a lytic and a latent phase. In the lytic phase a 
plethora of viral proteins and new infectious particles are produced, in the latent phase viral 
production ceases and only a very small set of viral latency-associated genes are expressed. 
In general, CMV binds to specific cell surface receptors and the viral envelope fuses with 
cellular membranes leading to the release of capsids into the cytoplasm. These capsids are 
then transferred into the nucleus, facilitated by cytoplasmic microtubules [3]. In the nucleus, 
the cellular and viral protein machineries manufacture new viral DNA and proteins. After 
autocatalytic assembly of the capsids in the nucleus, newly synthesized viral genomes are 
encapsidated. The nucleocapsid is then translocated to the cytoplasm by budding through the 
inner nuclear membrane. Together with the fusion of the primary envelope with the outer 
membrane and the release of the nucleocapsid into the cytoplasm, this process is called 
nuclear egress. In a next step, tegumentation and secondary envelopment take place. This 
includes a complex interaction of cytoplasmatic tegument proteins with the nucleocapsid and 
the future envelope resulting in infectious virions (reviewed in [4]). 
After a primary acute infection, herpesviruses can persist for a lifetime in their hosts in the 
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form of latency. During this latency, the lytic transcription program is suppressed, no 
infectious virus particles are produced and viral transcription is restricted to the expression of 
a few latency-associated transcripts [5]. Latency is interrupted by episodes of virus 
reactivation resulting in the biosynthesis and release of new virus particles. Extrinsic signals 
and conditions, such as immune cell depletion, allogenic transplantation and inflammatory 
disease states can trigger reactivation posing the risk of potentially life-threatening disease 
[6].  
One critical step for the establishment of latency and reactivation into the lytic phase is the 
regulation of the viral MIE promoter (MIEP). This promoter region controls the expression of 
the major viral immediate early (IE) genes. Hence, activation and silencing of this promoter is 
a credible mechanism to control viral lytic gene expression since the IE genes are crucial for 
the activation of all other viral genes upon lytic infection [7]. Multiple cellular transcription 
factors regulate the MIEP. While, among others, NF-κB, AP-1 and Sp1 have been shown to 
activate the MIEP, other cellular transcription factors like YY1 and ERF have been shown to 
repress the MIEP (reviewed in [8]). Interestingly, some of the transcriptional repressors, 
including YY1 and ERF, are transcription factors known to mediate transcriptional repression 
by recruitment of co-factors involved in post-translational modification of histones [9,10]. 
Hence, it is not surprising that ChIP assays showed the transcriptionally inactive MIEP, in 
latency, to be associated with markers of repressed chromatin and in contrast, the active MIEP 
with histone markers of transcriptional activation [11,12]. However, the mechanisms involved 
in the establishment of latency and the induction of reactivation are still not fully understood.  
 
I.1.2 Gene expression cascade 
 
Traditionally, CMV gene expression is categorized based on the time of synthesis during 
infection, thereby defining immediate early, early and late genes [13]. Once the viral DNA 
has entered the nucleus, transcription of immediate early genes, which require no protein 
synthesis for their expression, is initiated. As mentioned above, the MIEP controls the 
production of mRNAs encoding the viral major immediate early (IE) proteins. Furthermore, 
tegument proteins from the incoming particles act as viral transcription factors and can 
modulate IE gene expression [14]. The IE proteins then induce the expression of early genes 
which are in general transcribed prior to DNA replication. Proteins translated by that time are 
mainly important to modulate the host cell to favor and to establish viral replication [15]. 
Following the initiation of viral DNA replication, late gene expression is started. There are 
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two groups of late genes, the leaky-late genes expressed at low levels in early infection and 
dramatically up-regulated at late times and the “true” late genes expressed exclusively after 
viral DNA replication. These genes are required for assembly and egress and result in the 
production and release of infectious virus particles [16]. The mechanisms restricting viral late 
gene expression to after DNA replication is still poorly understood.  One major reason is the 
difficulty to recapitulate the appropriate kinetic regulation of late genes in cell culture. 
However, improvements and novel methods in the field of gene expression analysis will give 
rise to a more accurate picture of the complexity of CMV late gene regulation.  
 
I.1.3 Modulation of host cell gene expression 
 
Compared to other herpesviruses, the infection cycle of CMV is slow and no host shut-off 
takes place. Thus, viral modulation of the cell has to be very effective. Hence, especially in 
the first hours of lytic CMV infection, various modulations of the cell take place. Following 
attachment to the cell the virus is subjected to recognition by pattern-recognition receptors 
(PRRs) resulting in an innate immune response by activation of various cellular signal 
transduction pathways and proinflammatory cytokine production (reviewed in [17]). CMV 
has gained the ability to manipulate this early host inflammatory response towards its own 
needs. Thereby, one important example of modulation of the host cell response by the virus is 
the interaction with the NF-κB pathway. First, CMV activates the NF-κB response resulting 
in favorable conditions for viral replication. However, later in infection CMV inhibits the NF-
κB response, thereby dampening the inflammatory host response [18,19]. In this context, it 
was recently shown that the MCMV M45 protein plays a role in inhibiting the NF-κB 
response by proteasome-independent degradation of the NF-kB essential modulator (NEMO) 
leading to a novel mechanism of overcoming the host immune response [20]. As additional 
means of the virus, it has been hypothesized that stimulation of transcription factors by CMV 
in early infection is important for the subsequent viral replication. This is supported by a 
plethora of responsive DNA elements in the promoter/enhancer regions of CMV genes [21–
25].   
Like many other viruses, CMV dysregulates the host cell cycle machinery to its advantage. As 
such, CMV stimulates pro-proliferative cellular pathways, but once the infected cells reach 
the G1/S transition, the CMV IE2 protein inhibits further cell cycle progression by 
specifically blocking cellular DNA synthesis [26]. However, only DNA synthesis and cell 
division are blocked while other features of S-phase cells, such as an active nucleotide 
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metabolism and the expression of replication factors, are still induced [27]. At the same time, 
cell cycle checkpoints are by-passed [28,29] preventing apoptosis. All together this results in 
sufficient time for the virus to replicate in a favorable environment. CMV also encodes 
proteins to target apoptosis and thus to prevent cell death directly [30–32]. These anti-
apoptotic effects of CMV may permit prolonged viral infection and perhaps also facilitate 
chronic inflammation. 
During and after viral replication the cell is reprogrammed to support production and release 
of infectious viral particles. However, viral modulations of the host at late times of infection 
also lag far behind the understanding of viral-host interactions during early phase of infection. 
 
I.2 Gene expression profiling 
 
Gene expression profiling has enabled the simultaneous measurement of expression levels of 
thousands of genes in one RNA sample. Thereby, this analysis provides a genome-wide 
picture of the regulation of genes and pathways involved in many biological processes. RNA 
levels are determined by the interplay of tightly regulated processes for RNA production 
(transcription), processing (e.g. poly-adenylation or splicing) and degradation, resulting in a 
fine-tuned balance between RNA synthesis and decay which has to be considered when 
studying gene expression. 
 
I.2.1 Problems of standard gene expression analysis 
 
Numerous genome wide analyses have been performed on the progress of the cellular 
transcriptional response using total RNA. However, standard gene expression analyses on 
total RNA represent a static picture by only evaluating RNA abundance levels. This causes a 
number of problems. First, it is not easily possible to distinguish whether differentially 
expressed genes are regulated due to changes in transcription rate, RNA decay or a 
combination of both [33]. Second, fold changes detectable in total RNA do not reflect 
changes in RNA synthesis but are strongly dependent on transcript turnover rates, i.e. RNA 
half-lives. Therefore, the temporal resolution of gene expression studies on total RNA is 
rather low. To increase the detection level in standard gene expression, changes in total RNA 
levels are usually only analyzed hours after the initial stimulus was applied. Following such 
prolonged exposure, primary effects can no longer be distinguished from secondary 
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downstream effects [33]. In case short-term changes in gene expression are analyzed these are 
heavily biased for the detection of up-regulation of short-lived transcripts. As short-lived 
transcripts commonly encode for proteins with regulatory function substantial bias is 
introduced to all subsequent bioinformatics analyses.  
In consequence, the fundamental character of the alteration analyzing total RNA often 
remains elusive unless studied by additional means. Drugs, such as Actinomycin D [34], or 
thermal inactivation of temperature sensitive RNA Polymerase II [35] can be employed to 
inhibit transcriptional activity and thus, to study RNA decay. However, these methods affect 
cell growth and are inherently cell invasive, resulting again in substantial experimental bias.  
 
I.2.2 Metabolic labeling of newly transcribed RNA 
 
Direct measurements of RNA production rates are required to overcome these problems. 
Metabolic labeling of RNA with 4-thiouridine (4sU), termed 4sU-tagging, allows the 
purification of newly transcribed RNA from total RNA. Transcriptional activities become 
directly accessible in a non-disruptive way by introducing 4sU, a naturally occurring uridine 
derivative, into newly transcribed RNA utilizing salvage pathways. Following isolation of 
total cellular RNA, it is thiol-specifically biotinylated allowing separation of newly 
transcribed RNA from the total RNA [36]. 4sU–tagging is applicable to a broad range of 
organisms allowing a very sensitive and unbiased detection of differentially expressed genes 
[36–38]. In this context, work of this PhD thesis contributed, in cooperation with the group of 
Prof. Cramer, to the establishment of 4sU-tagging in yeast [39].  
By analyzing total RNA and newly transcribed RNA, e.g. by microarray or RNA-Seq, 
changes in gene expression can then be contributed to RNA synthesis or decay [40]. 
Alterations in newly transcribed RNA levels, which may not be visible in the total RNA at the 
same time, indicate changes in transcription rates, while changes in total RNA without a 
corresponding change in newly transcribed RNA are indicative of altered RNA stability [36]. 
Therefore, the temporal kinetics of the cell response to stimuli and to changes in conditions, 
such as viral infection, can now be properly studied. We thus applied 4sU-tagging to detail 
cellular and viral gene expression upon lytic infection of fibroblasts with the murine 
cytomegalovirus (MCMV). 
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I.3 MicroRNAs 
 
MicroRNAs (miRNAs) are a large family of endogenous ~22-nt non-coding RNAs. These 
regulatory RNAs provide a unique level of post-transcriptional gene regulation by binding to 
mRNAs in a sequence-specific manner. First identified in Caenorhabditis elegans, miRNAs 
are expressed by all metazoans and plants as well as by several DNA viruses and modulate a 
range of fundamental cellular processes such as development, differentiation, growth, stress 
response, apoptosis and immune activation (reviewed in [41]). To date, more than 15,000 
miRNAs have been annotated in over 140 species [42]. More than 45,000 miRNA target sites 
are computationally predicted in the 3’ untranslated regions (UTRs) of human mRNAs, 
indicating that miRNAs control the activity of ~60 % of all protein-coding genes. 
Furthermore, a single miRNA can potentially target over 300 different transcripts [43]. Taken 
together, this illustrates the influence miRNAs can have on regulation of gene expression. 
 
I.3.1 MicroRNAs as key regulators of cellular gene expression 
 
MicroRNA biogenesis typically begins with the nuclear transcription of a long primary 
miRNA (pri-miRNA), which is either transcribed by RNA polymerase II from an independent 
gene or represents an intron of a protein-coding gene [44]. Pri-miRNAs contain a 5’ cap, are 
polyadenylated and fold to produce one or more ~80-nt RNA hairpin structures. The hairpin 
structure is recognized and cleaved by the RNase III enzyme Drosha and its cofactor DGR8 to 
the precursor miRNA (pre-miRNA) in the nucleus. This pre-miRNA contains a 2-nt 3’ 
overhang which is recognized by Exportin 5 leading to the transport of the pre-miRNA to the 
cytoplasm. There, the same overhang is recognized by another RNase III enzyme, Dicer, and 
its cofactor TRBP producing a ~22 bp miRNA duplex intermediate flanked by 2-nt 3’ 
overhangs at each end [45,46]. The mature miRNA strand, the one which is less tightly base-
paired at the 5’ end, is then loaded into the RNA-induced silencing complex (RISC). The 
passenger strand, termed miRNA*, is degraded in the majority of cases. The RISC complex 
which is minimally composed of a mature miRNA and one of four Argonaute proteins (Ago1-
4) then functions to target mRNAs. For the targeting the 2nd to 7th 5’ nucleotides of the 
mature miRNA are important, termed the seed. Typically, the mature miRNA binds to 
complementary sequences found in the 3’ UTRs of target mRNAs (reviewed in [41]). The 
base-pairing of the miRNA with the target sequence inhibits protein synthesis either by 
repressing translation or promoting mRNA deadenylation and decay [47].   
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MicroRNAs are subjected to ingenious control themselves. In the last few years, several 
reports have shown that miRNA biogenenesis is heavily regulated. Hence, miRNAs regulate 
their own gene expression by autoregulatory feedback loops with specific transcription factors 
[48]. Furthermore, miRNA processing can be regulated by regulation of Drosha, Dicer and 
their co-factors. For example Dicer gets destabilized by dephosphorylation of its co-factor 
TRBP resulting in inhibition of pre-miRNA processing [49]. MicroRNA stability can also be 
affected. For example post-transcriptional addition of non-genome encoded nucleotides to the 
3’ end of either pre- or mature miRNAs results in protection or induction of degradation of 
miRNAs [50,51].  
Downstream of miRNA biogenesis, on the level of miRNA function, the miRNA pathway is 
also extensively controlled. These regulations mainly occur on effector steps of repression by 
miRNAs, especially by regulation of the RISC complex core components. In this context, the 
Ago proteins are the most obvious targets for regulation. For example Ago2 is stabilized by 
the heat shock protein Hsp90 under certain conditions resulting in impaired miRNA silencing 
[52]. In contrast to the mentioned options to regulate the miRNA pathway, turnover of 
miRNAs and mechanisms to regulate decay of miRNAs are still poorly understood and under 
strong investigation.  
 
I.3.2 MicroRNAs in herpesvirus infections 
 
In contrast to viral proteins, miRNAs are non-immunogenic, require little coding capacity and 
can evolve rapidly to target new transcripts. Thus, miRNAs are ideal tools for viruses to 
modulate gene expression. In 2004, virally encoded miRNAs were discovered in members of 
the herpesvirus family [53]. So far, viral miRNAs have been identified in 6 human 
herpesviruses, including HCMV, Epstein-Barr-Virus (EBV), Kaposi's sarcoma-associated 
herpesvirus (KSHV), herpes simplex virus 1 and 2 (HSV-1/-2) and human herpesvirus 6B 
(HHV6B) as well as in many animal models including the two murine herpesviruses MCMV 
and murine herpesvirus 68 (MHV68) [54–59]. Thereby, work of this PhD thesis contributed 
to the first miRNA target atlas of the two human gamma-herpesviruses, Kaposi-Sarkoma-
Virus and Epstein-Barr-Virus [60] as well as to the first functional phenotype of a viral 
miRNA knock-out virus [61]. 
The sequence-specific regulation of viral transcripts is easily achieved by herpesviruses 
through expression of antisense miRNAs. Hence, several latently expressed miRNAs upon 
HSV-1 infection are, for example, transcribed antisense to ICP0, which is a key immediate-
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early HSV-1 transcriptional activator and probably inhibited by these miRNAs during latency 
[62].  
Recently, the first direct and transcriptome-wide analyses of cellular herpesvirus miRNA 
targets were performed using Photoactivatable-Ribonucleoside-Enhanced Crosslinking and 
Immunoprecipitation (PAR-CLIP). For EBV and KSHV infection this resulted in the 
identification of several cellular pathways directly relevant for viral infection [63,64]. These 
studies and others showed that viral miRNAs target several cellular genes involved in cell 
proliferation, stress responses and antiviral defense pathways to favor the cellular 
environment for their needs. For KSHV it was for example shown that inhibition of apoptosis 
is supported by KSHV encoded miRNAs targeting caspase 3, important for apoptosis 
induction [65]. Interestingly, caspase 3 is not only targeted by one but by three KSHV 
encoded miRNAs indicating that cooperativity of viral miRNAs plays a role in targeting 
cellular mRNAs. MICB, another cellular protein, is targeted by several herpesvirus miRNAs, 
namely HCMV miR-UL112-1, KSHV miR-K7 and EBV miR-BART2, leading to a reduction 
on NK-cell mediated killing of infected cells [66,67]. MICB is the first gene found to be 
targeted by several herpesvirus miRNAs, which have no apparent sequence homology. 
Furthermore, HCMV miR-UL112-1 not only targets MICB but was also shown to have the 
potential to attenuate lytic replication of HCMV by targeting the IE72/IE1 transactivator [68], 
making it the first viral miRNA known to target both viral and cellular mRNAs.  
Besides expressing their own miRNAs, these viruses also learned to utilize cellular miRNAs 
to aid their needs. Wang et al. showed that infection with HCMV results in a down-regulation 
of miR-100 and miR-101 which play an important role in mTOR-signaling regulation [69]. 
This manipulation of cellular miRNA expression favors the cellular environment for viral 
replication.  
Recently, we reported on two cellular miRNAs, namely miR-27a and -b, to be targeted for 
degradation during lytic MCMV infection. Together with collaborators, we not only made the 
surprising observation that a viral gene is responsible for this function but that this interaction 
(m169 and miR-27) is indeed important for efficient virus replication in vivo [70]. During the 
course of this study the group of Joan Steitz reported herpesvirus samirii, an oncogenic 
monkey gamma-herpesvirus, to employ one of its non-coding RNA to specifically target the 
same two miRNAs, namely miR-27a/b, for degradation [71]. Elucidating why a murine beta-
herpesvirus and an oncogenic gamma-herpesvirus independently learned to target the same 
two cellular miRNAs for degradation will certainly provide important insights into 
herpesvirus biology. 
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I.4 Aims of this thesis 
 
CMV has acquired an extraordinary capacity to adapt to its host and has evolved numerous 
mechanisms to counteract the antiviral host defenses. Thus, CMV infection is an excellent 
model to study virus-host interactions. In this thesis the regulation of cellular and viral gene 
expression was studied at transcriptional and post-transcriptional level.  
4sU-tagging was established for lytic MCMV infection of fibroblasts and coupled to qRT-
PCR, microarray analysis and RNA-Seq to detail infection-induced changes in cellular 
transcription rates as well as rapid viral counter-regulation. As expected, due to the increase in 
temporal resolution, this revealed discrete functional networks of genes regulated with distinct 
kinetics and allowed an unbiased analysis of viral gene expression in absence of virion-
associated RNAs. 
There is increasing evidence that manipulation of cellular gene expression by both cellular 
and viral miRNAs is important in herpesvirus infections. At the beginning of this thesis, 
together with the labs of Sébastien Pfeffer and Amy Buck, we reported on the degradation of 
two cellular miRNAs, namely miR-27a/b, during lytic MCMV infection [70]. We 
hypothesized that this would be mediated by a viral gene product and thus screened large 
deletion mutants for the responsible gene. Once we had identified the gene, work focused on 
the underlying molecular mechanisms and the relevance of this interaction in vivo.  
 
 
 
 
 
 
II       Real-time transcriptional profiling of cellular and viral                                                                Introduction 
          gene expression during lytic cytomegalovirus infection  
 18 
Real-time transcriptional profiling of cellular and viral gene 
expression during lytic cytomegalovirus infection   
 
II.1 Introduction 
 
Herpesviruses are large DNA viruses, which cause a broad range of disease ranging from the 
common cold sore to cancer. They all share the ability to establish a life-long, latent infection, 
leaving the infected individual at constant risk of reactivation and subsequent disease. The 
human cytomegalovirus (HCMV) poses a severe threat to immunocompromised patients and 
represents the most common infective cause of congenital disorders affecting about 1 in 1,000 
newborns [72]. Like all herpesviruses, cytomegaloviruses (CMV) have co-evolved with their 
animal and human hosts for millions of years. During this time, they have mastered host-cell 
modulation to facilitate their needs and thus provide ideal tools to study many fundamental 
cellular processes. 
Numerous signaling events are triggered during the first few hours of infection. As such, 
binding of CMV particles to the cell membrane and virus entry result in the activation of  
cellular signaling pathways, some of which, e.g. NF-κB signaling, play an important role in 
initiating lytic viral infection [73–75]. Concomitantly, viral pathogen-associated molecular 
patterns are recognized by pattern-recognition receptors, resulting in robust activation of an 
innate immune response. Virion-associated proteins as well as the advent of viral gene 
expression then counteract intrinsic and arising host cell defense [15]. Several high-
throughput studies addressed the transcriptional response of the cell to lytic CMV infection by 
analyzing temporal changes in total RNA levels [18,76–80]. These studies revealed lytic 
CMV infection altered expression of numerous cellular genes involved in a variety of 
processes including inflammation, innate immunity, cell cycle progression, cellular 
metabolism and cell adhesion.  
One of the earliest events upon entry of the viral DNA into the nucleus is the deposition of 
viral genomes at nuclear domain (ND10) bodies [81,82]. This appears to be part of an 
intrinsic antiviral defense mechanism suppressing the expression of foreign DNA entering the 
nucleus [83]. In part, this is mediated by chromatin-remodeling enzymes recruited to these 
structures [84–86]. In HCMV infection, this intrinsic host defense is overcome by the viral 
tegument protein pp71 [87,88]. In lytic murine cytomegalovirus (MCMV) infection, 
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dispersion of ND10 bodies seems to be predominately mediated by the IE1 protein [89] and 
reviewed in [90]. In addition to disruption of ND10 body-mediated antiviral defense, the 
immediate-early proteins initiate the lytic replication cycle by facilitating the transcription of 
early genes [91,92]. The latter then modulate host cell environment, disarm the arising 
immune response, and establish the viral replication machinery. Upon viral DNA replication, 
viral late gene expression is initiated, culminating in the production and release of infectious 
virus particles [16].  
The analysis of de novo early viral gene expression has been substantially hindered by large 
amounts of so called ‘virion-associated RNA’, unspecifically bound by the virus particles and 
delivered to the newly infected cell [93–96]. Chromatin immunoprecipitation (ChIP) has thus 
been employed to study the kinetics of viral transcriptional activity by looking at markers of 
active and inactive chromatin associated with the viral promoters. Immediately upon infection 
of permissive fibroblasts (at ‘pre-IE’ times of infection, using low multiplicities of infection) 
HCMV genomes become associated with markers of repressed chromatin [97]. As infection 
progresses, the chromatin status of viral promoters reflects the cascade of viral immediate-
early, early and late gene expression [98,99].  
Standard gene expression analysis (using total RNA) to study kinetics of transcriptional 
regulation has several limitations.  First, short-term changes in total RNA levels do not match 
changes in transcription rates but are inherently dependent on the RNA half-life of the 
respective transcripts [36]. This strongly favors the detection of up-regulation of short-lived 
transcripts, commonly encoding for transcription factors and genes with regulatory function. 
This, in turn, may result in substantial bias in downstream bioinformatics analyses. Second, 
the temporal resolution - particularly for down-regulated genes - is rather low due to the 
relatively long median RNA half-life (5-10 h) in mammalian cells [33,100]. The same is true 
for detecting (viral) counter-regulation of cellular genes induced earlier in infection. Third, 
alterations in RNA synthesis rates cannot be differentiated from changes in RNA decay rates. 
Finally, transcriptional activity of the incoming CMV genomes cannot be definitively studied 
due to the presence of virion-associated RNA introduced to the newly infected cells by the 
incoming virus particles [95,101]. 
Recently, we developed an approach termed 4-thiouridine-(4sU)-tagging to purify newly 
transcribed RNA from total cellular RNA [36]. This is applicable to a broad range of 
organisms including vertebrates, drosophila and yeast [37,39]. In short, cells are cultured in 
presence of 4sU resulting in metabolic thiol-labeling of newly transcribed RNA. After 
isolation of total cellular RNA, RNA-incorporated 4sU is thiol-specifically biotinylated. 
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Labeled newly transcribed RNA is then efficiently purified from total RNA using 
streptavidin-coated magnetic beads. All three RNA fractions, i.e. total, newly transcribed and 
unlabeled pre-existing RNA, are suitable for quantitative RT-PCR (qRT-PCR), microarray 
analysis and next-generation sequencing [36,38,40,102]. In the present study, we employed 
this approach to lytic murine cytomegalovirus (MCMV) infection of fibroblasts to study the 
real-time kinetics of cellular and viral gene expression using qRT-PCR, microarray analysis 
and RNA-Sequencing (RNA-Seq). We show that this approach circumvents all the caveats 
mentioned above, thereby providing intriguing new insights into cytomegalovirus host-cell 
modulation and regulation of viral gene expression. 
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II.2 Materials and Methods 
 
Cell culture and virus infection 
Murine NIH-3T3 fibroblasts were cultured in DMEM (Gibco) supplemented with 5% fetal 
calf serum. Cells were seeded overnight to 80% confluence followed by infection with BAC-
derived MCMV Smith strain. Infection was performed at an MOI of 10 using centrifugal 
enhancement (30 min, 2000 rpm) or an MOI of 0.5. The time point after centrifugation was 
marked as time point ‘0 min’ in all experiments. To block RNA polymerase II transcription, 
Actinomycin-D (Sigma) was used at a final concentration of 5 µg/ml. UV irradiation of virus 
stocks was performed with 1500 J/m² UV light using a UV-Crosslinker (Vilber Loumart). 
Standard plaque assays were performed as described [103] to analyze the influence of 4sU on 
productive virus infection and to confirm the efficiency of UV-inactivation.  
 
Metabolic labeling and purification of newly transcribed RNA 
RNA labeling was started by adding 200 µM 4-thiouridine (4sU, Sigma) to cell culture media 
for 1 h at different times of infection. At the end of labeling, total cellular RNA was isolated 
using Trizol reagent (Invitrogen). Biotinylation and purification of 4sU-tagged RNA (newly 
transcribed RNA) as well as dot blot analysis were performed as described previously [36]. 
For all samples subjected to qRT-PCR analysis, DNase I (Fermentas) treatment was 
performed on total RNA according to the manufacturer’s instructions before biotinylation. 
RNA was recovered using the RNeasy Mini Kit (Qiagen).  
 
Reverse transcription and quantitative PCR 
Reverse transcription was carried out in 20 µl reactions using Superscript III (Invitrogen) and 
Oligo-dT primers (Invitrogen) following the manufacturer’s instruction. Samples were diluted 
1:5 with H2O before performing qRT-PCRs on a Light Cycler (Roche Molecular 
Biochemicals) as described in Dölken et al. [36]. Relative quantification was performed in 
relation to uninfected controls normalized to the housekeeping gene Lbr (Lamin B receptor). 
Primers were designed using the online Roche Universal Probe Library primer design tool 
spanning exon-exon junctions. All primers are listed in Table 1. 
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Table 1. All PCR primers used for qRT-PCR are shown 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Microarray analysis, data processing and statistical analysis 
For the microarray analysis, 200 ng RNA of each sample was amplified and labeled using the 
Affymetrix Whole-Transcript (WT) Sense Target Labeling Protocol without rRNA reduction. 
Affymetrix GeneChip Mouse Gene 1.0 ST arrays were hybridized, washed, stained, and 
scanned according to the protocol described in WT Sense Target Labeling Assay Manual. 
Microarray data were assessed for quality and normalized with RMA. All microarray data are 
available at Gene Expression Omnibus (GEO) record GSE35919. 
 
Quality control, normalization, filtering, statistical testing  
Data were analyzed using R and Bioconductor [104]. Only „present“ genes (i.e. expression 
values greater than 20 in at least 2 out of the total number of arrays for each RNA type) were 
included in downstream analysis. In the total RNA data set, n = 9,022 genes passed this filter; 
in the newly transcribed RNA data set, n = 9,399 genes passed. To better compare fold-
Primer Sequence 
LBR-for 5'-GGA AGT TTG TTG AGG GTG AAG TGG T-3' 
LBR-rev 5'-CCA GTT CGG TGC CAT CTT TGT ATT T-3' 
Nfkbia-for 5'-ACG AGC AAA TGG TGA AGG AG-3' 
Nfkbia-rev 5'-ATG ATT GCCAAG TGC AGG A-3' 
Ifit1-for 5'-TCT AAA CAG GGC CTT GCA G-3' 
Ifit1-rev 5'-GCA GAG CCC TTT TTG ATA ATG T-3' 
Gadd45a-for 5'-AGA GCA GAA GAC CGA AAG GA-3' 
Gadd45a-rev 5'-CGT AAT GGT GCG CTG ACT C-3' 
Herpud1-for 5'-ACC TGA GCC GAG TCT ACC C-3' 
Herpud1-rev 5'-AAC AGC AGC TTC CCA GAA TAA A-3' 
Lamb1-1-for 5-'TTG CGT GTG TTT GTG ATC CT-3' 
Lamb1-1-rev 5'-ATC CAG AGG CAC AGT CAT CA-3' 
Top2a-for 5'-CAA AAG AGT CAT CCC CCA AG-3' 
Top2a-rev 5'-GGG GTA CCC TCA ACG TTT TC-3' 
ie1-for 5'-TCA GCC ATC AAC TCT GCT ACC AAC-3'   
ie1-rev 5'-ATC TGA AAC AGC CGT ATA TCA TCT TG-3' 
m152-for 5'-CCC GCT CAT CCT CGA ATA-3' 
m152-rev 5'-CTC ATA AAC CGA GGC GAG AC-3' 
m169-for 5'-CAG GCA GAC ATC CGA AGG GAC TT-3' 
m169-rev 5'-TCT CCC CCC GTC CGT GAT CT-3' 
m129/131-for 5'-CCA CGT ACA TCA TGT CGG CG-3' 
m129/131-rev 5'-GGG ATG AGG GTG TGC GCT A-3' 
m94-for 5'-ACT GTG TCC TGC GAG GCC GA-3' 
m94-rev 5'-GCG TGT TCG CAC CGT CTT CC-3' 
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changes between the total and newly transcribed data, the set union of genes (n = 10,071) was 
used. Differentially expressed genes were identified  separately for the total RNA and newly 
transcribed RNA data sets using the LIMMA package. Differential expression was defined as 
having an estimated fold-change of at least 2 (calculated as the fold-change of the average 
expression in the triplicate measurements after infection compared to uninfected status) and a 
p-value smaller than 0.05 (adjusted for multiple testing using the Benjamini and Hochberg 
method [105]) (gene list see Table S1a). 
 
Grouping of differentially expressed genes into co-regulatory modules and gene-
ontology (GO) analysis 
Newly transcribed transcripts, which showed differential expression in at least one condition, 
were grouped into clusters based on their fold-changes upon MCMV infection. Five clusters 
were defined (for details see Table S1c). Gene Ontology analysis for each cluster was 
performed using the DAVID bioinformatics analysis suite (http://david.abcc.ncifcrf.gov/; 
release 6.7).  
 
Identification of over-represented transcription factor binding sites (TFBSs) in 
promoter regions 
For all probe sets with a mapped EnsEMBL ID, the core promoter sequence (-500 to +100 bp 
relative to the transcriptional start site (TSS) was retrieved using the Regulatory Sequence 
Analysis Tools (RSAT; http://rsat.ulb.ac.be/) retrieve EnsEMBL seq function. In case of 
alternative transcripts the most 5’ TSS was chosen. Over-represented TFBSs for each cluster 
were predicted using Transcription Factor Matrix (TFM) Explorer 
(http://bioinfo.lifl.fr/TFM/TFME/; release 2.0) [106]. Weight matrices modeling putative 
TFBSs were taken from TRANSFAC  (version 6.0 public; vertebrate matrices only). P-value 
thresholds to define locally over-represented TFBSs were set to 0.0001 and 0.00001 for 
clusters of less or more than 100 genes, respectively.  
 
Immunoblotting and immunofluorescence 
For immunoblotting, NIH-3T3 infected with MCMV were harvested in 500µl cell lysis buffer 
(62.5 mM Tris, 2% SDS, 10% glycerol, 6 M urea, 5% β-mercaptoethanol, 0.01% 
bromophenol blue, 0.01% phenol red) at several time points of infection. Following heat 
denaturation (95 °C, 5 min), 50 µl of the lysates were subjected to SDS-PAGE.  Proteins were 
transferred to a nitrocellulose membrane (Schleicher & Schuell) using a semidry blotter (Peq-
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Lab) (2 h, 400 mA). Membranes were blocked in PBS + 2.5 % milk powder and subsequently 
incubated with primary antibody (o/n, 4 °C). After incubation with horseradish peroxidase-
conjugated secondary antibody (1 h, RT) the proteins were visualized by the ECL system 
(Perkin Elmer) in the Fusion FX device (Vilber Lourmat).  
For indirect immunofluorescence NIH-3T3 cells were seeded onto fibronectin-coated glass 
cover-slips in 24-well plates and infected with MCMV. At various time points of infection, 
cells were fixed with 4 % paraformaldehyde in DPBS (w/v) for 10 min at 37° C. The fixative 
solution was replenished twice with DPBS and the cells were permeabilized for 10 minutes 
with a solution of 0.1% Triton X-100 in DPBS. After extensive washing with DPBS, the cells 
were blocked using 3 % (w/v) BSA in DPBS (blocking solution) for 1 h at room temperature 
(RT). Primary antibodies were applied in blocking solution and incubated with the cells at RT 
for 1 h followed by three DPBS washing steps and 1 h incubation at RT with 1:1,000 dilutions 
of Alexa Fluor-conjugated, specific secondary antibodies (Invitrogen) in blocking solution. 
After a final washing step with DPBS, the preparations were mounted on glass slides with 
Prolong Gold including DAPI (Invitrogen) and analyzed using an LSM 710 (Zeiss) confocal 
laser scanning microscope with 405 nm, 488 nm and 561 nm laser excitation and appropriate 
filter sets. 
The following primary antibodies were used for immunoblotting and -fluorescence: mouse 
anti-IE1 (CROMA101; kindly provided by S. Jonijic, University of Rijeka, Rijeka, 
Croatia), rabbit anti-GAPDH (mAbcam 9484) from Abcam, rabbit anti-RelA (A) and mouse 
anti-IκB-α (H4) from Santa Cruz Biotechnology. 
 
Luciferase assays 
To monitor the activity of c-Myc-regulated signal transduction pathway, cells were 
transfected in a 6-well format using the Cignal c-Myc-Reporter (luc) Kit from Qiagen. 6 
hours post transfection cells were seeded in 96-well plates (10,000 cells / well). 48 hours after 
seeding, the transfected cells were infected with MCMV (n=3). At various times of infection, 
cells were lysed in 100 µl lysis buffer and luciferase firefly activity was determined according 
to the manufacturer´s (Promega) instructions.  
 
Next Generation Sequencing 
RNA was subjected to WTAK library construction to generate transcriptomic fragment 
libraries (50 bp, SOLiD™ (Life Technologies, Foster City, CA, USA) Total RNA-Seq Kit 
V3) that preserve strandedness information of the reads. Molecular barcoding was used in 
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order to pool several libraries in a single sequencing reaction according to the 
manunfacturer´s protocol. Sequencing was performed using the SOLiDTM 3 system (Life 
Technologies). Potential sequencing errors were corrected using the SOLiD Accuracy 
Enhancement Tool (solidsoftwaretools.com/gt/project/saet). All sequencing data are available 
at Gene Expression Omnibus (GEO) at GSE35833.   
 
Short-read alignment, MCMV read coverage 
Between 26 and 42 million 50 nt reads were obtained per sample (Table S2). Reads were 
aligned in a 4-step process using the Bowtie alignment program. First, all reads were aligned 
to mouse transcripts (Ensembl version 63). Remaining unaligned reads were aligned to the 
mouse genome (mm9, NCBI Build 37). Remaining reads were aligned to MCMV coding 
sequences and finally to the full MCMV genomic sequence. Reads with ambiguous base calls, 
non-unique alignment positions or more than 4 mismatches were discarded. Reads were 
classified as exon-exon and exon-intron junction reads, respectively, if they overlapped an 
exon-exon or an exon-intron junction by ≥ 1 nt. MCMV genome cover age was scaled before 
plotting. Scaling factors were derived using DESeq  based on reads aligned to mouse exons. 
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II.3 Results 
 
Establishment of 4sU-tagging for lytic MCMV infection 
Upon its addition to the cell culture medium, 4-thiouridine (4sU) is rapidly taken up by cells, 
phosphorylated and incorporated into newly transcribed RNA in a concentration-dependent 
manner [36]. To establish 4sU-tagging for MCMV infection, we first analyzed the effect of 
lytic MCMV infection on 4sU-incorporation. NIH-3T3 fibroblasts were infected with MCMV 
at a multiplicity of infection (MOI) of 10. At different times of infection, 200 µM 4sU was 
added to the cell culture medium for 1 h. Total RNA was prepared and subjected to thiol-
specific biotinylation. 4sU-(biotin)-incorporation was quantified by dot blot (Figure 1A). At 
all times of infection, 4sU-incorporation was at least as efficient as in uninfected cells, 
ensuring efficient purification of newly transcribed RNA at all times of infection. 
Interestingly, from 5 to 24 hours post infection (hpi) the extent of 4sU-incorporation into 
cellular RNA was about 20-fold greater than in uninfected cells. By 47-48 hpi this had 
returned to levels found in uninfected cells. These data are consistent with increased 
transcriptional activity as well as enhanced nucleoside metabolism during lytic CMV 
infection [107].  
 
 
Figure 1. Establishment of 4sU-tagging for lytic MCMV infection 
(A) Incorporation of 4sU throughout MCMV infection. Cells were infected with MCMV at an MOI of 10 and 
exposed to 200 µM 4sU for 1 h at different times of infection before total RNA was isolated. Thiol-specifically 
biotinylated RNA was subjected to dot blot analysis in 10-fold dilutions (1 µg down to 1 ng). A biotinylated 
oligonucleotide of 81 nt (PC, 100 ng down to 0.1 ng) was used to quantify 4sU-incorporation; M = mock 
control. (B)-(D) Comparison of genes identified to be regulated in newly transcribed RNA to genes regulated in 
total RNA. (B) Numbers of genes up- and down-regulated (>2-fold, p≤0.05) at different times of infection are 
shown for newly transcribed RNA and total RNA. (C) Venn diagrams of all genes regulated more then 2-fold in 
newly transcribed RNA and total RNA. (D) Venn diagrams showing genes regulated >2-fold in total RNA at 2, 
4 and 6 hpi and in newly transcribed RNA at and prior to the indicated time point of infection; red = newly 
transcribed RNA, blue = total RNA. 
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Metabolic labeling of newly transcribed RNA with 4sU has negligible polar effects on 
eukaryotic cells [36,108]. To exclude gross adverse effects of 4sU-labeling on MCMV 
replication, we applied 1h of 200 µM 4sU-treatment to NIH-3T3 cells at different times of 
infection. No effect of 4sU exposure on virus titers, determined at 48 hpi, was observed 
(Figure 2). We therefore decided to use 1h of 200 µM 4sU in all following experiments. 
 
 
Figure 2. No effect of 1 h 200 µM 4sU treatment on virus replication  
NIH-3T3 fibroblasts were infected with MCMV at an MOI of 10 for 48 h. Samples were exposed to 200 µM 
4sU for 1 h at different time points of infection or left untreated. Supernatants were harvested and titrated at 48 
hpi. Shown are the means +/- SD of three biological replicates. 
 
Kinetics of transcriptional activity of cellular genes during early MCMV infection 
To detail transcriptional changes in host gene expression during early MCMV infection we 
infected NIH-3T3 fibroblasts with MCMV at an MOI of 10 and labeled newly transcribed 
RNA from 1-2, 3-4 and 5-6 hpi. Three replicates of both total and newly transcribed RNA 
were subjected to Affymetrix Gene ST 1.0 arrays. After Robust Multichip Average (RMA) 
normalization, we identified all genes significantly regulated (p≤0.05) by at least 2 -fold 
compared to uninfected cells in any condition. This resulted in the identification of 1,674 
probe sets showing differential expression (Table S1a). With the exception of 4 genes, all 
differentially expressed genes were either exclusively up- or down-regulated during the first 6 
h of infection. The number of genes with differential expression detectable in total RNA only 
represented 13 % (at 2 hpi), 25 % (at 4 hpi) and 54 % (at 6 hpi) of those identified in newly 
transcribed RNA. As predicted, down-regulation only started to become detectable in total 
RNA with substantial delay, i.e. at 4 hpi (Figure 1B). Furthermore, a peak of MCMV-induced 
and rapidly counter-regulated gene expression was apparent in newly transcribed RNA at 3-4 
hpi. This was invisible in total RNA. The overlap of differential gene expression detectable at 
different times of infection was substantially greater for newly transcribed RNA (Figure 1C). 
Notably, we found all genes induced or repressed by at least 2-fold in total RNA at 6 hpi to 
show concordant regulation in newly transcribed RNA (Figure 1D). In addition, only 3 probe 
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sets showed more than 2-fold greater regulation in total RNA than in newly transcribed RNA 
(genes listed in Table S1b). Hence, the vast majority of differential gene expression during the 
first six hours of MCMV infection is the result of alterations in transcription rates and not due 
to changes in RNA decay rates. We therefore decided to focus all our subsequent analyses on 
newly transcribed RNA.  
 
4sU-tagging details discrete functional gene clusters regulated with distinct kinetics  
Clustering genes based on >2-fold differences in regulation at different times of infection, we 
identified 5 clusters of genes characterized by distinct kinetic profiles (Figure 3A; for details 
and genes represented in each cluster see Table S1c). MCMV-induced genes peaked at 1-2 
(Cluster 1), 3-4 (Cluster 2) or 5-6 hpi (Cluster 3). Of these, Cluster 2 was not detectable in 
total cellular RNA at all. Rapid and rather constant down-regulation was characteristic of 
genes in Cluster 4, while genes in Cluster 5 showed delayed down-regulation. To look for 
functional characteristics of these five gene clusters, we performed Gene Ontology (GO) 
analysis. Interestingly, all five clusters were associated with distinct GO terms (see Figure 
3B). Genes in Cluster 1 were involved in immune and inflammatory processes as well as 
apoptosis. Genes in Cluster 2 mainly played a role in p53 signaling and cell cycle progression. 
Delayed induction was observed for genes involved in the ER stress response (Cluster 3). 
Rapid and sustained down-regulation was observed for genes involved in cell proliferation 
and differentiation, focal adhesion as well as actin filament-based processes (Cluster 4). 
Finally, delayed down-regulation was characteristic of genes with a role in chromatin 
assembly and cell cycle processes (Cluster 5). Due to the delayed visibility of down-
regulation in total RNA (see Figure 1B), Cluster 4 and 5 could only be differentiated using 
newly transcribed RNA. This approach thus allowed dissecting differential gene expression 
into discrete functional clusters regulated with distinct kinetics. These provided us with ideal 
templates to elucidate the underlying transcription factors and molecular mechanisms using in 
silico promoter analysis. 
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Figure 3. Gene expression kinetics define distinct functional clusters 
(A) Heat-maps indicating the fold-changes are shown as matrices with rows representing genes and columns 
representing the time points post infection. Red represents up-regulation, blue down-regulation (>2-fold, p≤0.05) 
in newly transcribed RNA relative to uninfected cells. Ordering of genes in the heat-maps was determined using 
non-supervised hierarchical clustering. Shown are the 5 clusters of genes we identified. (B) All clusters are 
associated with distinct functional annotations. Gene Ontology analyses are shown for each of the five clusters 
with the most significant (p≤0.05) categories displayed in the graphs as bars, sorted from bottom (most 
significant) to top. (C) Specific transcription factor binding sites correlate with functional clusters. Shown are 
exemplary transcription factors with over-represented binding sites unique for the different clusters. Illustrated 
are the transcription factor weight matrices, the percentage of promoters with sites and p-value.  
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Promoter analysis associates distinct transcription factors with each individual gene 
cluster 
We performed promoter analysis on the five clusters to identify cellular transcription factors 
(TFs) involved in their regulation. Proximal promoter regions (PPR) ranging from -500 to 
+100 bp from the transcription start site (TSS) were analyzed for over-represented 
transcription factor binding motifs. While a number of transcription factor binding motifs 
were significantly over-represented in the five clusters (for complete list and data see Table 
S3), we observed distinct transcription factor binding sites to be uniquely over-represented in 
each of the individual clusters (see Figure 3C). These correlated very well with the functional 
annotations of the associated clusters.  
Two exemplary TFs were chosen for further validation. As a proof-of-principle TF, we 
decided to look at NF-κB to see whether it’s well-described rapid induction and counter-
regulation during CMV infection [43–45] would precisely reflect the transcriptional changes 
we observed in newly transcribed RNA under our experimental conditions. NF-κB-dimers of 
the NF-κB- (p105 and p100) and Rel-subfamily (c-Rel, RelB and RelA) are present in 
inactive IκB-bound complexes in the cytoplasm. IκK-mediated phosphorylation induces 
degradation of the inhibitor IkBα, enabling translocation of the NF-κB dimers to the nucleus 
and enhanced transcription of NF-κB target genes (reviewed in [111]). To look for 
degradation of the inhibitor IκBα during the first 12 h of MCMV infection, we performed 
immunoblotting (Figure 4A). In addition, immunofluorescence analysis was performed to 
reveal the shift of RelA into the nucleus (Figure 4B). Results from both experiments 
demonstrated the kinetics of transcriptional regulation of genes in Cluster 1 to precisely 
mirror NF-κB activation, highlighting the ability of 4sU-tagging to detail real-time 
transcription factor activity.  
In addition, we looked at a representative TF of Cluster 3, namely c-Myc. c-Myc is a proto-
oncogene which drives cell cycle progression and apoptosis, whereas cellular differentiation 
and cell adhesion are negatively influenced [112]. c-Myc forms a heterodimer with Max, 
followed by its binding to target genes [113]. Furthermore, phosphorylation of two amino 
acids at the NH2-terminal domain is important for transactivation of c-Myc [114]. Hagemeier 
et al. showed that HCMV IE1 and IE2 can transactivate the c-Myc promoter [115]. We 
performed luciferase assays using a c-Myc-specific reporter construct transfected into NIH-
3T3 cells 48 h prior to infection to analyze c-Myc activation. Luciferase activity started to 
significantly increase at 4 hpi, matching the expression kinetics of genes in Cluster 3 (Figure 
4C).  
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Figure 4. Validation of exemplary transcription factors 
NIH-3T3 fibroblasts were infected with MCMV at an MOI of 10 for the indicated time points and lysates were 
prepared for western blot analysis (A), for immune staining (B) or luciferase assay (C). Western blot analysis 
was performed on samples prepared from uninfected and infected NIH-3T3 cells probed for RelA and IkBα (A). 
GAPDH was probed as loading control. For the immunofluorescence staining (B) cells were fixed and stained 
with the indicated antibodies; white circle indicating nucleus, DAPI nuclear staining; green, RelA; red, viral IE1. 
For the luciferase assays cells were transfected with a c-Myc-reporter construct (C) and infected 48 hours post 
transfection with MCMV at an MOI of 10. At the indicated times post infection, Firefly-Luciferase 
measurements were performed in triplicates. Shown is the mean +/- SD of a representative of three experiment; 
mpi =minutes post infection, hpi = hours post infection. 
 
Virus-mediated regulation and counter-regulation of host gene expression 
We then addressed the role of viral gene expression in the regulation of each cluster using 
infection with UV-inactivated virus. To provide a more comprehensive picture, we extended 
the kinetics until 48 hpi. To this end, NIH-3T3 cells were infected with either wild-type (wt) 
or UV-inactivated virus. RNA was labeled for 1 h at different times of infection and newly 
transcribed RNA was purified. Transcription rates of exemplary genes of each functional 
cluster were determined in newly transcribed RNA using quantitative RT-PCR (qRT-PCR). 
This included NF-κB- (Cluster 1), interferon- (Cluster 1), DNA-damage- (Cluster 2) and ER-
stress- (Cluster 3) induced genes as well as MCMV-repressed genes involved in the 
regulation of cell differentiation (Cluster 4) and cell cycle/chromatin organization (Cluster 5). 
The housekeeping gene Lbr (Lamin B receptor) was used for normalization.  
Cluster 1 contains both NF-κB- as well as interferon-induced genes. We thus chose NF-κBiα 
(NF-κB-inhibitor alpha), an NF-κB-induced negative regulator of the NF-κB response, as well 
as Ifit1 (Interferon-induced protein with tetratricopeptide repeats 1) for this analysis. Both 
NF-κBiα and Ifit1 were rapidly induced and counter-regulated by lytic MCMV infection 
(Figure 5A, B). Induction of both genes following infection with UV-inactivated virus was 
comparable to wt-MCMV infection, consistent with previous reports showing that viral gene 
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expression is not required for induction of both NF-κB- and interferon-signaling. In both 
cases, however, counter-regulation was substantially delayed following infection with UV-
inactivated virus. While counter-regulation of the NF-κB response is consistent with the 
MCMV M45 gene product efficiently targeting NF-κB- signaling [20] a viral gene product 
targeting the induction of the interferon response remains to be identified [116].  
To monitor DNA-damage response-mediated signaling, we analyzed transcriptional activity 
of Gadd45a (Growth arrest and DNA damage-inducible protein A), a well characterized DNA 
damage- induced gene [117]. Consistent with our microarray data, qRT-PCR revealed the 
same slightly delayed induction at 3-4 hpi, followed by a more protracted counter-regulation 
than we observed for NF-κBiα and Ifit1. Interestingly, UV-inactivated virus also triggered the 
induction of Gadd45a with similar kinetics. This was, however, no longer counter-regulated, 
but continued to increase until 48 hpi (Figure 5C). While these data are indicative of counter-
regulation of the underlying DNA-damage response by an MCMV gene product, we cannot 
exclude that the enhanced response - at least in parts - reflects increased activation by the UV-
damaged viral DNA. For HCMV, it was described that Gadd45a interacts with the anti-
apoptotic UL37x1 gene product and increases its anti-apoptotic function early in infection 
[118]. Thus, the induction of Cluster 2 may at least in parts represent an intended action of the 
virus. 
For Cluster 3, expression of Herpud1 (Homocysteine-responsive endoplasmic reticulum-
resident ubiquitin-like domain member 1 protein), a gene induced by endoplasmatic reticulum 
(ER) stress [119], was monitored. Delayed induction was observed, which was rapidly 
counter-regulated. Induction of Herpud1 was lost upon infection with UV-inactivated virus, 
consistent with viral gene expression being required for the induction of the ER stress 
response. In summary, these findings indicate that a so far unknown viral gene product 
counteracts the ER stress response provoked by viral gene expression (Figure 5D). For 
HCMV, this function is thought to be performed by the viral pUL38 protein [120].   
For Clusters 4 and 5 we chose to monitor the transcription kinetics of Lamb1-1 (Laminin beta 
1), an important extracellular matrix glycoprotein, and Top2α(Topoisomerase 2 alpha), which 
is involved in the control and alteration of the topologic states of DNA during transcription 
[121,122]. Interestingly, consistent down-regulation of both genes was observed following 
wt-MCMV, but not UV-MCMV infection, indicating that viral gene expression is required for 
both their regulation (Figure 5 E, F).  
In summary, these data highlight that all cellular signaling pathways we identified to be 
induced during early MCMV infection are rapidly counter-regulated by the virus later on. In 
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contrast, down-regulation of defined cellular signaling pathways prevails and thus most likely 
represents an intentional action of the virus to facilitate its needs.  
 
 
Figure 5. Identification of virus-specific regulation and counter-regulation using UV-inactivated virus  
Quantitative RT-PCR was employed to measure transcription rates of exemplary genes of the five gene clusters 
(A-F). NIH-3T3 were infected with wt- or UV-inactivated (1500J, 15min) MCMV (MOI of 10) for the indicated 
time points. Displayed are the fold-changes relative to uninfected cells normalized to Lbr. Fold-changes in 
between 0.5- and 2-fold were considered as non-regulated. Shown are the combined data (means +/- SD) of three 
independent experiments. 
 
Analysis of newly transcribed RNA allows studying viral gene expression in absence of 
virion-associated RNA 
Cytomegalovirus particles unspecifically incorporate and transfer large amounts of so called 
‘virion-associated RNA’ to newly infected cells [95]. This has substantially hindered detailed 
studies on the kinetics of viral gene expression during the first few hours of infection and in 
latency. 4sU-tagging allows the removal of virion-associated RNA and thus, the dissection of 
the regulation of viral gene expression during the initial phase of infection. To show that 4sU-
tagged newly transcribed RNA fraction is indeed free of virion-associated RNA, we labeled 
newly transcribed RNA in MCMV infected NIH-3T3 cells from 1-2, 3-4 and 7-8 hpi in the 
presence and absence of the RNA polymerase II inhibitor Actinomycin D (Act-D). Act-D 
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treatment inhibits RNA synthesis and thus prevents 4sU-incorporation into newly transcribed 
RNA. Following isolation of total RNA, we included a DNase digest prior to biotinylation to 
further remove viral DNA. Newly transcribed and total RNA samples were subjected to qRT-
PCR analysis for the spliced viral ie1 gene and the cellular housekeeping gene Lbr. In total 
RNA, large amounts of IE1 transcripts were detectable even in presence of Act-D, consistent 
with large amounts of virion-associated RNA delivered to the infected cells. However, in 
newly transcribed RNA virtually no IE1 and Lbr transcripts (below detection limit of our 
qRT-PCR assay) were detectable in presence of Act-D, consistent with the complete removal 
of virion-associated RNA (Figure 6A).  
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Figure 6. Real-time kinetics of viral gene expression 
(A) 4sU-tagging allows efficient removal of viral DNA and virion-associated RNA. Newly transcribed RNA was 
labeled with 200 µM 4sU for 1 h in MCMV-infected NIH-3T3 cells at -1 to 0 (mock), 1-2, 3-4 and 7-8 hpi. As a 
negative control, Actinomycin-D was added to cells prior to infection to block transcription and thus 4sU-
incorporation. Total RNA was isolated, treated with DNaseI and newly transcribed RNA was purified. qRT-PCR 
analysis was performed on newly transcribed RNA for viral IE1 and cellular Lbr. Shown are the combined data 
(means +/- SD) of three independent experiments. (B-F) Gene expression kinetics of exemplary viral genes. 
Shown are qRT-PCR measurements of newly transcribed RNA for IE1 (B), the early genes m169 (C) and m152 
(D) as well as for the late genes m129/131 (E) and M94 (F). Synthesis rates were normalized to Lbr expression. 
Shown are the combined data (means +/- SD) of three independent experiments. (G) Contribution of viral 
transcripts to all coding sequence reads (CDS). RNA-Seq was performed on newly transcribed, total and 
unlabeled pre-existing RNA samples (n=1). Reads were mapped to both the cellular and viral 
transcriptome/genome. The contribution of viral reads to all CDS reads at different times of infection is shown. 
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4sU-tagging reveals a peak of viral gene expression at 1-2 hpi, including immediate-
early, early and even late gene expression 
We then performed a comprehensive time-course analysis of transcriptional activity during 
lytic MCMV infection. To study relevant time frames, we first determined the kinetics of viral 
DNA replication in NIH-3T3 cells infected with wt-MCMV at an MOI of 10. Both qRT-PCR 
on M54, the catalytic subunit of MCMV DNA polymerase, and southern blot analysis of 
concatameric DNA revealed viral DNA replication to start at ~15 hpi (Figure 7).  
 
 
Figure 7.  Temporal kinetics of MCMV replication 
NIH-3T3 cells were infected with MCMV at an MOI of 10. DNA was isolated at various times of infection using 
the DNeasy Blood & Tissue Kit (Qiagen) according to the manufacturer’s instructions. Prior to amplification, 
extracted DNA was digested with PaeI for 1 h, 37 °C followed by heat inactivation.  (A) TaqMan qRT-PCR was 
performed in triplicates for MCMV M54 and cellular Lbr using the ABI Prism 7700 sequence detector (Applied 
Biosystems) as described [123]. Synthesis rates were normalized to Lbr. Shown are the means +/- SD of three 
independent experiments. (B) Southern Blot analysis was performed as described in Popa et al. [124]. Shown is 
the detection of different genome fragments in DNA isolated from NIH-3T3 cells at various times of infection. 
MCMV BAC-DNA (BAC) served as a negative control. The 3 kb fragment serves as a measurement of genomic 
load, the 2 kb fragment for concatameric/circular DNA and the 1 kb fragment for linear, unique length genomic 
DNA. The appearance of the 1kb DNA fragment indicates the onset of viral DNA replication. Due to its circular 
form, digested BAC DNA produces only two of the three fragments.  
 
We therefore decided to label newly transcribed RNA at 1-2 hpi, 5-6 hpi, 11-12 hpi (prior to 
the onset of DNA replication), 18-19 hpi (during DNA replication, but prior to the first 
release of virus particles), 24-25 hpi (first infectious virus particles starting to be released) and 
at 47-48 hpi (late stage infection). Following DNase digest and purification of newly 
transcribed RNA, this was subjected to qRT-PCR analysis for IE1 as well as two genes well 
characterized to be expressed with either early (m152 and m169) or late (m129/131 and M94) 
kinetics [125–127]. For the spliced late gene m129/m131 [128] we designed the qRT-PCR to 
span exon-exon junctions to further eliminate any residual risk of amplifying viral DNA or 
II        Real-time transcriptional profiling of cellular and viral                                                                       Results 
           gene expression during lytic cytomegalovirus infection  
 37 
transcripts derived from the opposite DNA strand. To our great surprise, we found not only 
the two early, but also the two late genes to be well expressed during the first few hours of 
infection peaking at 1-2 hpi followed by a down-regulation at 5-6 hpi ( 6B-F). It is important 
to note that we could not detect any specific signals in any assay when qRT-PCR was carried 
out using non-reverse-transcribed samples or Act-D-treated samples (data not shown). This 
demonstrated the complete removal of viral DNA and virion-associated RNA from these 
samples. Expression of M94 was also observed when strand-specific cDNA synthesis was 
performed, matching the kinetics shown in Figure 6F (data not shown). In addition, agarose 
electrophoresis on m129/m131-PCR products confirmed a band of the predicted size, thereby 
excluding amplification of viral DNA or a transcript expressed from the opposite DNA strand 
(data not shown).  
A second unexpected finding was the dramatic drop of transcriptional activity of all viral 
genes starting 3-4 hpi. For IE1 and m169, transcription dropped >30-fold by 5-6 hpi 
(compared to 1-2 hpi) and then leveled off (Figure 6B, C). In contrast, transcription rates of 
m152 continued to drop exceeding 500-fold at 47-48 hpi (Figure 6D). Both late genes, i.e. 
m129/m131 and M94, showed a substantial increase in synthesis rates with the onset of viral 
DNA replication, consistent with their kinetic class. To rule out that our observations were 
simply caused by the high MOI, we repeated the experiment using a low MOI of 0.5. As 
observed with high MOI, IE1 transcription had already peaked by 1-2 hpi. In contrast, 
transcription rates of both the two early and late genes had not, now peaking at 3-4 hpi (see 
Figure 8). Nevertheless, transcription rates of all five genes significantly dropped by 5-6 hpi. 
These data indicate that transient expression of viral late genes during the first few hours of 
infection is not an artifact of high MOI. 
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Figure 8. Regulation of viral gene expression following low and high MOI 
NIH-3T3 cells were infected with (A) an MOI of 0.5 (low MOI) and (B) an MOI of 10 (high MOI, data taken 
from Figure 6B-F). Newly transcribed RNA was labeled from -1 to 0 (mock), 1-2, 3-4 and 5-6 hpi. Following 
purification of newly transcribed RNA, expression levels of IE1, m152, m169, m129/131 and M94 were 
determined by qRT-PCR normalized for Lbr. 
 
RNA-Seq reveals rapid silencing of viral gene expression after the initiation of early 
gene expression 
To confirm these observations at the whole transcriptome level, we repeated the experiment 
described above and subjected newly transcribed RNA samples from 7 time points (mock, 1-
2, 5-6, 11-12, 18-19, 24-25 and 47-48 hpi) to SOLiD 3 sequencing. In addition, we included 
samples of total and pre-existing RNA (mock, 25 hpi and 48 hpi). We obtained between 16 
and 42 million reads per sample, which were mapped to the mouse transcriptome, mouse 
genome, MCMV predicted coding sequences and the MCMV genome in the respective order. 
As expected, introns were substantially over-represented in newly transcribed RNA (Figure 9) 
reflecting the substantially greater contribution of immature, unspliced nascent transcripts 
[38]. 
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Figure 9. Classification of reads aligned to mouse transcripts and genomic sequence 
Reads were classified according to their alignment position in mouse transcripts or genomic sequence as exon, 
intron, exon-exon junction, or exon-intron junction reads. Shown are the relative frequencies of each class for 
total, pre-existing, and newly transcribed RNA samples derived from NIH-3T3 cells at various times of 
infection. The high fraction of intronic reads in newly transcribed RNA samples is consistent with the increased 
proportion of premature transcripts present in newly transcribed RNA. 
 
When considering only coding sequences, viral transcripts accounted for ~20% of all reads in 
total RNA at 48 hpi and in newly transcribed RNA at 47-48 hpi (Figure 6G). Interestingly, the 
extent of viral gene expression in newly transcribed RNA at 1-2 hpi also accounted for ~15% 
of all reads, dropping to around 5% of all reads at 5-6 hpi. This corroborates our qRT-PCR 
finding of a burst of viral gene expression at 1-2 hpi, but also highlights that not all viral 
genes expressed at 1-2 hpi are subject to the same massive down-regulation we observed for 
m152. A closer look at the distribution of transcription rates across the whole viral genome 
(direct and complementary strand) revealed viral gene expression arising from multiple loci at 
1-2 hpi (Figure 10). By 5-6 hpi, transcription rates of many but not all viral genes dropped 
substantially. With the onset of viral DNA replication, late gene expression was initiated, 
accounting for the increasing number of viral reads at 24-25 and 47-48 hpi (although of 
shifted viral gene subsets compared to 1-2 hpi). At late stages of infection, transcription rates 
of viral genes stabilized, reflected by the continuous accumulation of the respective viral 
transcripts in both total and unlabeled pre-existing RNA (Figure 11).  
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Figure 10. Analysis of MCMV gene expression by RNA-Seq 
Shown are the coverages of all viral genes across the MCMV genome obtained by RNA-Seq on newly 
transcribed RNA from uninfected cells, 1-2 hpi, 5-6 hpi, 11-12 hpi, 18-19 hpi, 24-25 hpi and 47-48 hpi, 
normalized to the total number of mapped exonic mouse reads. Genomic positions of exemplary genes as well as 
concordantly regulated gene clusters are marked; SCP = small capsid protein (m48.2), POL = polymerase 
(M54). Blue represents transcripts matching the direct DNA strand and red the complementary DNA strand. 
 
                                                                       
II        Real-time transcriptional profiling of cellular and viral                                                                       Results 
           gene expression during lytic cytomegalovirus infection  
 41 
 
Figure 11. RNA-Seq data on MCMV gene expression using total RNA and unlabeled pre-existing RNA 
Shown are the read coverages of all viral genes across the whole MCMV genome obtained by RNA-Seq for 
uninfected cells for (A) newly transcribed RNA samples and 25 hpi and 48 hpi for (B) total RNA samples and 
(C) pre-existing RNA samples normalized to the total number of mapped exonic mouse reads. Positions of 
exemplary genes as well as representative gene clusters showing concordant regulation are indicated; SCP = 
small capsid protein (m48.2), POL = polymerase (M54). Blue represent reads matching to the direct DNA strand 
and red represents reads matching to the complementary DNA strand. 
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II.4 Discussion 
 
In this work, we first employed 4sU-tagging combined with microarray analysis to study the 
dynamic changes in transcriptional activity of NIH-3T3 fibroblasts during early MCMV 
infection. Interestingly, we found virtually all changes in total cellular RNA to be matched by 
concordant changes in newly transcribed RNA, indicating that alterations in RNA decay rates 
do not substantially contribute to differential gene expression during early phase of MCMV 
infection of fibroblasts. This is consistent with previous reports showing that alterations in 
RNA decay rates do not seem to provide a major contribution during the first 3 h of the 
response of fibroblasts to type I and II interferons [36] or of dendritic cells to 
lipopolysaccharides [38]. It is important to note that the high MOI we employed facilitated 
the initiation of a fast, contemporaneous infection, crucial to dissect the temporal cascade of 
rapid transcriptional changes during lytic MCMV infection. This approach revealed extensive 
regulation, which remained undetectable in total cellular RNA. These elements of the host 
response to lytic infection are of particular interest because they are likely to be subjected to 
rapid viral counter-regulation. Analysis of newly transcribed RNA combined with the use of 
UV-inactivated virus detailed such rapid viral counter-regulation for inflammatory-, 
interferon-, DNA-damage- and ER-stress-induced changes. While numerous MCMV proteins 
have been shown to counteract the consequences of the induced ER-stress response, i.e. the 
induction of stress-induced natural killer cell activating ligands (reviewed in [129]), little is 
known about the counter-regulation of ER-stress signaling itself. The same is true for the very 
transient DNA-damage response we observed. The rapid counter-regulation in transcriptional 
activity revealed by newly transcribed RNA implies the existence of novel viral factors 
targeting these important cellular processes. Furthermore, our approach will now allow 
screening of large deletion mutants for the responsible viral genes.  
Analysis of newly transcribed RNA revealed delayed down-regulation of genes involved in 
chromatin modification as well as down-regulation of genes involved in cell proliferation and 
actin filament-based processes. Within a few hours of infection, MCMV-infected cells show a 
profound cytopathic effect. The underlying molecular events remain to be elucidated. It is 
tempting to speculate that transcriptional down-regulation of genes involved in actin filament-
based processes and cell adhesion, which we found to be consistently down-regulated as early 
as 1-2 hpi, contributes to this phenomenon.  
As we exemplified for both NF-κB and c-Myc, changes in transcriptional activity (as 
detectable in newly transcribed RNA) directly mirror the changes in the activation status of 
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the involved transcription factors. In addition, the ability to group the large number of 
differentially regulated genes (as usually identified when analyzing total RNA changes) into 
well-defined functional clusters of genes (regulated with distinct kinetics) further aids the 
subsequent success of in silico promoter analyses. Our approach thus provides an ideal mean 
to obtain insights into the molecular mechanisms/transcription factors involved. It is 
important to note that most of the transcription factors, implicated by our promoter analysis, 
have already been associated with the functional annotations of the respective gene clusters. 
In addition, many of the transcription factors specifically over-represented in the clusters (see 
Table S3) were consistent with published data on their functional role in lytic CMV infection.  
Of interest, E2F-sites were significantly over-represented in genes repressed with delayed 
kinetics (Cluster 5). The E2F family consists of both activating and repressing transcription 
factors (for review see [130,131]). The activating E2F family members, E2F-1, -2 and -3, are 
important for the transactivation of target genes involved in G1/S transition and apoptosis. 
E2F-4 and -5 predominantly have repressive functions, mediating cell-cycle exit and cell 
differentiation. E2F-6, -7 and -8 also act as transcriptional repressors, but are less well 
characterized. A caveat of this is that the DNA-binding sites of the E2F-family members 
cannot be differentiated from each other by bioinformatics means, highlighting the 
complexity of this regulation. Therefore, the repression of genes in Cluster 5 could either be 
mediated by repression of activating E2F-family members (E2F-1,-2 and -3) or activation of 
repressive family members like E2F-4 and -5. Interestingly, the most significantly associated 
gene ontology for Cluster 5 was not ‘G1/S-phase of the mitotic cell cycle’, as would have 
been expected in case of E2F-1-associated regulation, but ‘M-phase of the mitotic cell cycle’. 
Recently, the LIN complex (LINC), which involves the repressive E2F-4 family member, was 
shown to selectively repress genes involved in G2/M phase [132]. A closer look at the genes 
of Cluster 5 revealed the presence of numerous genes reported by this and other work [133] to 
be key marker-genes repressed by the LINC complex (which involves E2F-4). These included 
Survivin (Birc5), Cyclin B1, Aurkb, Espl1 and Bub1. It is thus tempting to speculate that the 
repression of genes in Cluster 5 is mediated not by repression of activating E2F-family 
members, but by activation of repressive E2F-family members (involving LINC). Ongoing 
work seeks to clarify the role of E2F-family members in this regulation. Lytic HCMV 
infection has been shown to result in E2F-1 activation by rapid degradation of the under-
phosphorylated form of pRB by the HCMV protein pp71 [134,135] and to increase E2F-1 
responsive genes [136]. Of note, we did not observe over-representation of E2F sites in any of 
the MCMV-induced gene clusters. While HCMV can only induce lytic infection in G0/G1 
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phase, MCMV can also efficiently replicate in cells that have passed through S phase by 
arresting them in G2 [137]. Differences in shifting cell populations may thus account for the 
lack of E2F-1 over-representation in our MCMV-induced gene clusters.  
4sU-tagging provides the unique opportunity to study the regulation of viral gene expression 
in real-time without the interference of virion-associated RNAs. Employing 4sU-tagging 
combined with qRT-PCR and RNA-Seq to lytic MCMV infection, we report on three 
surprising findings. 1) A peak of viral gene expression including expression of immediate-
early, early and even well-characterized late genes at 1-2 hpi at both high and low MOI. 2) 
The rapid suppression of all three classes of viral gene expression by 5-6 hpi. 3) Very 
constant levels of viral gene transcription rates (e.g. for IE1 and m169) or even continuously 
increasing suppression (e.g. m152), despite the onset of extensive viral DNA replication. 
Both qRT-PCR and RNA-Seq on newly transcribed RNA revealed a peak of transcriptional 
activity of viral genes at 1-2 h of lytic MCMV infection, to an extent only reached again at 
late stages of infection (47-48 hpi). We were surprised to observe that this even included 
transcription of well-characterized late genes, e.g. m129-131 and M94. Rigorous controls 
excluded DNA contamination, virion-associated RNA and gene expression from the opposing 
DNA strand. Furthermore, this transcriptional activity was also observed at low MOI. In this 
case, however, the peak of both early (m152 and m169) and late (M94 and m129/131) gene 
expression slightly shifted from 1-2 hpi to 3-4 hpi, thus separating this from the peak of 
immediate-early gene expression, which still had already peaked at 1-2 hpi. This shift 
strongly argues against ‘leaky’ promoters being responsible for this late gene expression, but 
rather highlights a role of virus-mediated regulation (most likely mediated by IE- or viral 
tegument-proteins) in facilitating this part of viral gene expression. At present, it is unclear 
whether the respective transcripts are actually translated. Recent reports indicate regulation 
occurring at the level of translation to provide a major contribution to overall regulation of 
mammalian gene expression [102]. It is tempting to speculate that the virus uses additional, so 
far undisclosed mechanisms, to regulate its gene expression at post-transcriptional level. Of 
note, previous studies already postulated a role of post-transcriptional regulation in HCMV 
[138] and expression of some HCMV genes has already been shown to be regulated at post-
transcriptional level [139,140]. 
Interestingly, the peak of viral gene expression we observed at 1-2 hpi was followed by a 
rapid drop in transcription rates by 6-12 hpi. We were surprised to see this rapid down-
regulation of early gene epression. Interestingly, this was sustained or even exaggerated at 
late times of infection. What is the cause of this down-regulation? Chromatin modifications of 
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the viral genome are well known to play an important role during productive CMV infection 
(reviewed in [141]). The ND10 body-associated protein Daxx is known to rapidly repress 
transcription of incoming viral genomes by inducing repressive chromatin modifications 
around the HCMV major immediate-early promoter (MIEP) within 3 hpi. Dependent on the 
MOI of infection, the virus is able to overcome this repression. This results in the 
inhibition/reversion of HDAC-mediated repression of the viral genomes present in the 
nucleus and initiates the expression of early genes [89,142]. It is important to note that the 
peak of early gene expression should thus only occur after ND10 body-mediated repression 
has already been efficiently disrupted. Our data are fully consistent with this hypothesis. 
While we observed both immediate-early and early gene expression to peak or already have 
peaked at 1-2 hpi following high MOI (consistent with rapid disruption of ND-10 bodies), 
low MOI resulted in a visible delay between the peak of immediate-early and early gene 
expression. This is consistent with a delayed dispersion of ND-10 body-mediated repression 
of early gene expression at low MOI. Of note, we observed repression of viral gene 
expression after the peak of early gene expression, i.e. after ND-10 bodies have already been 
dispersed. Therefore, this suppression, which we observed by both qRT-PCR and RNA-Seq 
to occur in between 6 and 12 hpi, is unlikely to be due to the intrinsic antiviral defense known 
to be mediated by ND-10 bodies.  
Interestingly, transcription of some genes, e.g. ie1 and m169 substantially dropped and then 
continued at low level despite the onset of viral DNA replication (i.e. a rapid >100-fold 
increase in viral DNA load). The most likely explanation for this observation is that the DNA 
architecture of de novo synthesized viral genomes does not support transcription of (at least) 
some viral genes. On the other hand, it is tempting to speculate that these differences in 
chromatin structure play an important role in initiating viral late gene expression. 
Interestingly, transcription rates of some viral genes, e.g. m152, continuoued to drop 
(exceeding 500-fold compared to 1-2 hpi) until 47-48 hpi. These observations highlight the 
importance of transcription factors in the regulation of viral gene expression. Activation or 
repression of these transcription factors will also influence the expression of the cellular genes 
they govern. The kinetics of viral gene expression during the first few hours of infection best 
matches those of cellular genes within the Clusters 1 and 2. This is consistent with the well 
described presence of binding sites for NF-κB and even interferon stimulated response 
elements (ISRE) in many viral promoters [143,144]. The changes in transcription factor 
activity following the advent of viral DNA replication are less well understood. 4sU-tagging 
now allows us to properly study the changes in cellular gene expression following the onset of 
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viral DNA replication. Correlating these with the changes in viral gene expression will 
substantially enhance our understanding of how these viruses modulate the host-cell 
machinery for their own needs and pinpoint novel targets for antiviral intervention. 
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Degradation of cellular miR-27 by a novel, highly abundant viral 
transcript is important for efficient virus replication in vivo 
 
III.1 Introduction 
 
MicroRNAs (miRNAs) are small non-coding RNA molecules, which are involved in a broad 
range of biological processes. They represent an evolutionary highly conserved mechanism 
present in virtually all multicellular organisms ranging from fungi to mammals (reviewed 
in [145]). MiRNA biogenesis is a stepwise process involving the sequential action of the 
RNase III enzymes Drosha and Dicer, generating a ~22 nucleotide (nt) miRNA duplex. One 
strand of the duplex is then loaded into the RNA-induced silencing complex (RISC), while 
the other strand, known as the passenger strand or star sequence (miRNA*), is often, but not 
always, actively degraded. Upon assembly into the RISC complex, which invariably contains 
a member of the Argonaute protein family, they regulate gene expression 
either via translational inhibition, and/or destabilization of the targeted transcript. To date, 
more than 1,400 miRNAs have been identified in humans [146]. Once incorporated into 
RISC, the loaded miRNA is thought to be rather stable, with a half-life in the range of 
days [147]. 
In the last few years, tremendous progress has been made regarding the functional role of 
miRNA-mediated regulation of gene expression, resulting in the identification of thousands of 
miRNA target sites [148–150]. However, much less is known about the regulation of small 
RNAs themselves. Regulation of miRNA expression levels has been described to occur at the 
level of transcription, processing, and stability (reviewed in [145]). Nevertheless, the 
underlying molecular mechanisms are not always clearly understood. As such, it has been 
reported that the regulation of the maturation step of the let-7 miRNA precursor is subject to 
regulation via the interaction of Lin28 with its terminal loop. After binding to the pre-miRNA, 
Lin28 recruits the terminal uridyltransferase Zcchc11, which mediates tailing of the 3′ end of 
the small RNA [151–153]. The modification of small RNAs by nucleotide addition is not only 
observed for pre-miRNAs, mature miRNAs can also be modified. This was initially reported 
in the plant model Arabidopsis thaliana, whereby miRNAs are usually methylated at their 3′ 
end by the methyl transferase HEN1 [154]. In a HEN1 mutant background, the absence of the 
2′-O-methyl group on small RNAs triggers their 3′ end tailing, usually by uridylation, to bring 
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about their degradation [155]. It has thus been proposed that the 2′ -O-methylation of plant 
small RNAs, which also occurs on animal Piwi-interacting RNAs (piRNAs) [156,157] 
actually functions to protect the small RNAs against uridylation and subsequent degradation. 
Recently, it was described that the interaction between a small RNA and its target can in some 
cases (extensive base pairing) also result in the degradation of the miRNA [158]. 
Interestingly, this was found to be accompanied by 3′ -tailing and -trimming of the miRNA. 
However, the molecular mechanisms involved still remain to be identified. 
Regulation of miRNA expression occurs in response to both biotic and abiotic stresses [159]. 
Among the former, viral infections represent a prominent part and are known to interact 
extensively with the RNA silencing machinery. In mammals, this is best exemplified by the 
hijacking of the miRNA machinery by viruses, especially herpesviruses, to express their own 
miRNAs [160]. The use of small, non-immunogenic RNA molecules to regulate their own, as 
well as cellular gene e[161]xpression, is yet another illustration of the extensive adaptation of 
these viruses to their hosts - the result of millions of years of coevolution [162]. In addition to 
expressing their own miRNAs, viruses also interact with cellular miRNAs. For example, miR-
32 plays an antiviral role upon primate foamy virus infection, and both miR-24 and miR-93 
negatively regulate the vesicular stomatitis virus [163]. A recent study revealed a number of 
cellular miRNAs with apparently intrinsic antiviral properties [164], highlighting the need for 
viruses to engage in the alteration of the cellular miRNA profile. It is therefore not surprising 
that the expression levels of some cellular miRNAs are deregulated during viral infection. 
Recently, we showed that lytic mouse cytomegalovirus (MCMV) infection, besides 
expressing large numbers of viral miRNAs [58], results in the dramatic destabilization of two 
cellular miRNAs, namely miR-27a and miR-27b [70]. MiR-27a is encoded within a miRNA 
cluster located on chromosome 8, along with miR-23a and miR-24-2. It possesses an isoform 
located on chromosome 13, miR-27b that is clustered with miR-23b and miR-24-1. 
Strikingly, only the level of the mature forms of miR-27a and 27b were affected upon MCMV 
infection, while the levels of miR-27a* and miR-27b* remained unaltered. We thus 
hypothesized MCMV to encode a transcript targeting miR-27a/b for rapid degradation by a 
yet to be identified molecular mechanism. Interestingly, during the course of this work 
Cazalla et al.identified the herpesvirus saimiri HSUR1 transcript to bind to, and target miR-
27a/b for degradation [71]. 
Here, we report on the identification of the MCMV transcript, encoded by the m169 gene, 
which mediates the rapid degradation of both miR-27a and 27b. We found this down-
regulation to be accompanied by 3′ -tailing and -trimming of the miRNA. Specificity to miR-
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27a/b is mediated via a single binding site located in the m169 3′ -UTR. Replacement of this 
target site allowed for efficient retargeting of the transcript to other cellular and viral 
miRNAs. Despite its dramatic effect on miRNA stability, we found this interaction to be 
mutual, resulting in miR-27a/b-mediated regulation of m169. We thus performed infections of 
mice with the mutant viruses we generated, which lost the ability to degrade miR-27a/b, but 
retained regulation by a retargeted cellular or viral miRNA. Results from these experiments 
reveal that the interplay between the m169 transcript and cellular miRNAs is important during 
acute MCMV infection in vivo. 
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III.2 Materials and Methods 
 
Ethic statement 
All of the protocols used for breeding of mice and different kinds of treatments were 
approved by the Ethical Committee of the Faculty of Medicine University of Rijeka and were 
performed in accordance with Croatian Law for the Protection of Laboratory Animals, which 
has been harmonized with the existing EU legislation (EC Directive 86/609/EEC). 
 
Cell lines 
BALB/c murine embryonic fibroblasts (MEFs) and M2-10B4 bone marrow stroma cells 
(ATCC: CRL-1972) were cultured in DMEM containing 10% fetal calf serum and 
penicillin/streptomycin. NIH-3T3 fibroblasts (ATCC: CRL-1658) were cultured in DMEM 
medium containing 5% fetal calf serum and penicillin/streptomycin. 
 
Generation of mutant viruses 
Generation of deletion mutants to screen for the gene responsible for miR-27a/b degradation 
was performed as described previously [165] using the full-length MCMV BAC 
pSM3fr [166]. All PCR primers are included in Table 2A. Markerless BAC mutagenesis was 
performed to introduce more subtle changes into the MCMV m169 locus. This was performed 
according to previously published protocols [167,168]. Briefly, an I-SceI-aphAI cassette was 
amplified from the plasmid pEPKAN-S by 2-step PCR using the different sets of primers 
included in Table 2B. In the first Red recombination step these PCR fragments were inserted 
into pSM3fr, resulting in a BAC carrying a kanamycin resistance cassette flanked by I-SceI 
restriction sites. The kanamycin resistance cassette was then removed from kanamycin-
resistant clones by an arabinose-induced I-SceI digestion and subsequent heat-induced Red 
recombination, resulting in markerless mutagenesis of the miR-27a/b binding site in m169.  
The revertant virus (MCMV-m169-mut-rev) was generated from the m169-mut BAC by 
completely restoring the wild-type sequence, i.e. reverting all three point mutations to wild-
type sequence. All mutant BACs were subjected to extensive restriction pattern analysis using 
at least three different restriction enzymes followed by sequencing of the altered m169 locus. 
All viruses were reconstituted by transfecting the recombinant BACs into murine embryonic 
fibroblasts and virus titers were determined on MEFs by standard plaque assay as 
described [165]. 
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Table 2. List of all primers used for cloning 
A. Primers used for generation of MCMV deletion mutants using ET-cloning. B. Primers used for generation of 
MCMV mutants using Markerless mutagenesis [167]. 
A 
Δ7S.1-gfp 
F: 5' AACTGGAAAATATAGTTAGCACCGTTAGAGAGGGCGACAGATTTCGATCACTACAAGGACGACGACGACA 
AGTAA 3' 
  
R: 5' CGGCGCGAAGACACAGACGTATAGCGCTGTACGTCCTACCGAATCGCGGTGTGACACAGGAACACTTAAC 
GGCTGA 3' 
    
Δ7S.2-gfp 
F: 5' GAAAGCCCCATGTCTATCGGAAACACACTACGGTTCAAGAGAGGGCCCTACTACAAGGACGACGACGACA 
AGTAA 3' 
  
R: 5' GCGGGCGTCCAGAGACAGAGGACTCCGGCGGCGGACACTAACGATCCGGGGTGACACAGGAACACTTAA 
CGGCTGA 3' 
    
Δ7S.3-gfp 
F: 5' CGAACGTCGATCCAAACACCCTCTTCCGCACGCGCAGCTGCTGGCCCTCACTACAAGGACGACGACGAC 
AAGTAA 3' 
  
R: 5' ATGTGCTCGGTTAACGAGTTGGCCTTCGTCCGGCTGTCCGGCACGACTACGTGACACAGGAACACTTAA 
CGGCTGA 3' 
    
Δm167 
F: 5' CGAACGTCGATCCAAACACCCTCTTCCGCACGCGCAGCTGCTGGCCCTCACTACAAGGACGACGACGACA 
AGTAA 3' 
  
R: 5' ATGCTCACGTGGCAGAGTGTGGAAACTTTGACAGCGGATGTTGCGACCCGACAGGAACACTTAACGGCT 
GA 3' 
    
Δm168 
F: 5' ATGCGAGGACGGACACACGAGGGAAGGATGTATGTGCGTGAAAGAACACGTAGGACGACGACGACAAG 
TAA 3' 
  
R: 5' CGACTGCCCGTCTCCTTCGGAGTAGAAACTCTATCCTCGGAGCGATCCTCGCAGGAACACTTAACGGCT 
GA 3' 
    
Δm169 
F: 5' GAACACTTTCGGTGACATGAACGATGAAGTGGCGGGAGAAAGTAGCAAGCTCAGGACGACGACGACAAG 
TAA 3' 
  
R: 5' ATGAGCAACGCGGTCCCGTTCGTCCCCTACGCGGGTATCGGCCACAACCTCAGGAACACTTAACGGCT 
GA 3' 
    
Δm170 
F: 5'CCTGGTACCTGCGCGGCGGTCAACCCGTAACGCCTGTAGCATGCCGGCGGGAGGACGACGACGACAAGT 
AA 3' 
  
R: 5' ATGCTCACGTGGCAGAGTGTGGAAACTTTGACAGCGGATGTTGCGACCCGAAGGAACACTTAACGGCTG 
A 3' 
 
B 
Generation of MCMV-m169-mut  
1. PCR 
H5-m169-pepkan  5’-tgaggagaccgttctcaggcagacatccgaagggacttctttCcaTagTttattattccgcagatcgtcgtctgggggagatA GGATGACGACGATAAGTAGGG-3’ 
Pepkan rev 5’-CAACCAATTAACCAATTCTGATTAG-3’ 
  
2. PCR 
H3-m169-pepkan 
5’- CCTCGGAGCGATCCTCGTCCGCCGTCTCCCCCCGTCCGTGATCTCCCCCAGA 
CGACGATCTGCGGAATAATAAACTATGGAAAGAAGTCCCTTCGGATGTCTCAACCAATT
AACCAATTCTGATTAG-3’ 
m169 pepkan-for 5’- TGAGGAGACCGTTCTCAGGCAGAC-3’ 
 
Generation of MCMV-m169-rev 
H5-m169-rep 5‘-AGTAGCATCTCCCGATGAGGAGACCGTTCTCAGGCAGACATCCGAAGGGAC TTCTTTTCACAGCTTATTATTCCGCAGAT AGGATGACGACGATAAGTAGGG-3‘ 
Pepkan rev 5’-CAACCAATTAACCAATTCTGATTAG-3’ 
  
2. PCR 
H3-m169-rep 
 
 5'-TCCGCCGTCTCCCCCCGTCCGTGATCTCCCCCAGACGACGATCTGCGGAAT 
AATAAGCTGTGAAAAGAAGTCCCTTCGGACAACCAATTAACCAATTCTGATTAG-5‘ 
m169 pepkan-for 5’- TGAGGAGACCGTTCTCAGGCAGAC-3’ 
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Generation of MCMV-m169-miR-16 
1. PCR 
H5-m169-miR-16-
pepkan 
 5’-tgaggagaccgttctcaggcagacatccgaagggacttcttagcagcaaaccctattggcggatcgtcgtctgg 
gggagat AGGATGACGACGATAAGTAGGG-3’ 
Pepkan rev  5’-CAACCAATTAACCAATTCTGATTAG-3’ 
  
2. PCR 
H3-m169-miR-16-
pepkan  
 5‘-CCTCGGAGCGATCCTCGTCCGCCGTCTCCCCCCGTCCGTGATCTCCCCCAG 
ACGACGATCCGCCAATAGGGTTTGCTGCTAAGAAGTCCCTTCGGATGTCTCAACCAATT
AACCAATTCTGATTAG-3’ 
m169 pepkan-for 5’- TGAGGAGACCGTTCTCAGGCAGAC-3’ 
 
Generation of MCMV-m169-miR-M23-2 
1. PCR 
H5-m169-miR-M23-
2-pepkan 
5’-tgaggagaccgttctcaggcagacatccgaagggacttctatgggggcgtttacaagcgggatcgtcgtctgggggggat 
AGGATGACGACGATAAGTAGGG-3’ 
Pepkan rev 5’-CAACCAATTAACCAATTCTGATTAG-3’ 
  
2. PCR 
H3-m169-miR-M23-
2-pepkan 
5’- CCTCGGAGCGATCCTCGTCCGCCGTCTCCCCCCGTCCGTGATCTCCCCCAG 
ACGACGATCCCGCTTGTAAACGCCCCCATAGAAGTCCCTTCGGATGTCTCAACCAATTA
ACCAATTCTGATTAG-3’ 
m169 pepkan-for 5’- TGAGGAGACCGTTCTCAGGCAGAC-3’ 
 
Generation of MCMV-m169-PRS-mut 
1. PCR 
H5-m169-bHuR-1 
pepkan 
5'-ACGGACACACGAGGGAAGGATGTATGTGCGTGAAAGAACACGTTCTCGTTT 
CTTTCTTCTTGCGTATTGCATTCAAGTAGCATCTAGGATGACGACGATAAGTAGGG-3’ 
Pepkan rev 5’-CAACCAATTAACCAATTCTGATTAG-3’ 
  
2. PCR 
m169-bHuR-1-for  5’-ACGGACACACGAGGGAAGGATGT -3’ 
H3-m169-bHuR-1 
pepkan  
5'-TCCCTTCGGATGTCTGCCTGAGAACGGTCTCCTCATCGGGAGATGCTACTT 
GAATGCAATACGCAAGAAGAAAGAAACGACAACCAATTAACCAATTCTGATTAG-3’ 
 
Generation of adenoviruses expressing full-length or parts of m169 
Adenoviral vectors expressing either full-length m169, or its 3′ -UTR fused to EGFP under 
control of the cellular EF1-promoter were generated by Sirion Biotech, Martinsried, 
Germany. An adenovirus expressing mCherry served as control. To increase transduction 
efficiency of NIH-3T3 cells, TransMAX enhancer reagent (Sirion Biotech) was used 
following the manufacturer's instruction using an MOI of 50 and 500 (titers derived from 
infection of HEK-293 cells, corresponding to an MOI of about 5 and 50 in NIH-3T3 cells). 
 
Infection of NIH-3T3 cells 
Six-well plates were seeded with 0.5×106 cells one day prior to infection in DMEM 
containing 10% fetal calf serum. Cells were infected with indicated viruses at an MOI of 1 
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followed by centrifugal enhancement (800 g, 30 min), resulting in an effective MOI of ~10; 
culture media was replaced following one hour of infection. 
 
Quantifying changes in miRNA levels by qRT-PCR 
NIH-3T3 cells were infected with wild-type MCMV or mutant viruses at an MOI of 10. 48 h 
post infection RNA was prepared using either Trizol reagent (Invitrogen) or miRNeasy 
columns (Qiagen) following the manufacturers' instructions. cDNA was prepared in a single 
step reaction for both miRNAs and larger transcripts using the miScript Reverse Transcription 
kit (Qiagen). Light Cycler qRT-PCR was performed for various cellular and viral miRNAs 
using the miScript SYBR Green PCR kit (Qiagen) following the manufacturer's instructions. 
In each case the nucleotide sequence of the mature target miRNA was used to design the 
miRNA-specific forward primer. The PCR program was composed of a denaturation step at 
94°C for 12 min followed by 45 cycles of 95°C for 15 sec (ramp rate 20°C/sec), 55°C for 30 
sec (ramp rate 20°C/sec; 60°C for mRNA targets) and 70°C for 1 sec (ramp rate 2°C/sec). A 
list of all PCR primers is provided in Table 3. 
 
Table 3. List of all primers used for qRT-PCR 
 
miR-27a-for 5'-TTCACAGTGGCTAAGTTCCGC-3' 
miR-24-for 5'-TGGCTCAGTTCAGCAGGAACAG-3' 
miR-16-for 5'-TAGCAGCACGTAAATATTGGCG-3' 
    
m169-for 5´-CAGGCAGACATCCGAAGGGACTT-3 
m169-rev  5´-TCTCCCCCCGTCCGTGATCT-3 
    
IE1-for 5'-TCA GCC ATC AAC TCT GCT ACC AAC-3'   
IE1-rev 5'-ATC TGA AAC AGC CGT ATA TCA TCT TG-3' 
    
gapdh-for  5'-TGT CAA GCT CAT TTC CTG GTA TGA-3' 
gapdh-rev 5'-CTT ACT CCT TGG AGG CCA TGT AG-3' 
    
LBR-for 5'-GGA AGT TTG TTG AGG GTG AAG TGG T-3' 
LBR-rev 5'-CCA GTT CGG TGC CAT CTT TGT ATT T-3' 
    
irf1-for 5'-AGA GCC AGA TCC CAA GAC ATG GAA-3' 
irf1-rev 5'-ACA GCA GAG CTG CCC TTG TTC CTA-3' 
 
Immunoprecipitation of mouse Argonaute 2 complexes 
To determine whether the m169 transcript was recruited to Ago2-complexes, 
immunoprecipitation of miRNA/target complexes was performed using the recently published 
antibody to mouse Ago2 [169]. Per replicate, ten large (15 cm) dishes of NIH-3T3 cells were 
infected with an MOI of 10 for 0, 6 or 12 h with wild-type MCMV. Cells were washed twice 
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with PBS before lysis in 10 ml lysis buffer, containing 25 mM Tris HCl pH 7.5, 150 mM 
KCl, 2 mM EDTA, 0.5% NP-40, 0.5 mM DTT, and Complete protease inhibitor (Roche). 
DTT and protease inhibitors were always prepared freshly and added immediately before use. 
Lysates were incubated for 30 min at 4°C and cleared by centrifugation at 20,000 g for 30 
min at 4°C. Total RNA was prepared from 100 µL of cell lysates using the miRNeasy kit 
(Qiagen) following the manufacturer's instructions. Ago2-immunoprecipitation was 
performed as recently described [60]. In short, 6 µg of purified monoclonal mAgo2-antibody 
(2D4, Wako) or monoclonal BrdU-antibody (Abcam; used as control) was added to 5 mL of 
RPMI-medium and incubated with 30 µL of Protein-G-Sepharose beads (GE Healthcare) in 
Pierce centrifuge columns (Thermo Scientific) under constant rotation at 4°C over night. 
Columns were drained by gravity flow and washed once with the lysis buffer. Beads were 
subsequently incubated with 5 mL of cell lysates for 2.5 h under constant rotation at 4°C. 
After incubation, the beads were washed four times with IP wash buffer (300 mM NaCl, 50 
mM Tris HCl pH 7.5, 5 mM MgCl2, 0.1% NP-40, 1 mM NaF) and once with PBS to remove 
residual detergents. RNA was recovered from the beads by adding 700 µl of Qiazol to the 
columns. After 5 min the Qiazol lysates were collected from the columns. This step was 
repeated once and the Qiazol lysates were combined. RNA was prepared using the miRNeasy 
kit (Qiagen) according to the manufacturer's instructions. RNA samples were eluted in 30 µL 
of H2O. Efficiency of the immunoprecipitation was checked by qRT-PCR for miR-16 and 
let7a. 
 
Northern blot analysis 
Small RNAs. RNA was extracted using Trizol and northern blotting was performed on 10 µg 
of total RNA. Briefly, total RNA was resolved on a 17.5% acrylamide gel of 30 cm in length. 
RNA was transferred by semi-dry transfer (BioRad TransBlot SD) to a Hybond-NX 
membrane (GE Healthcare). RNAs were then cross-linked to the membrane by EDC cross-
linking as described in Pall and Hamilton [170] with a 90 min incubation step at 65°C. 
Prehybridization, hybridization, and wash steps were performed at 50°C. Probes either 
consisted of 5′ -32P-radiolabelled oligodeoxynucleotides only or oligodeoxynucleotides 
containing Locked Nucleic Acid positions for the detection of tailed forms of miR-27 
(Eurogentec). They are perfectly complementary to the miRNA sequence or to part of the U6 
snRNA sequence. 
m169 transcript. Total RNA samples (1 µg) were mixed with equal volumes of loading dye 
and heated at 65°C for 10 minutes prior to separation on a 1.2% agarose/formaldehyde gel. 
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RNA was transferred overnight to a Hybond-NX membrane (GE Healthcare) by standard 
capillary transfer methods and crosslinked with UV. Membranes were prehybridized for 2 hrs 
in PerfectHyb™ plus (Sigma) at 50°C. Antisense DNA oligos for m169 (5′-
GGACGGGGGGAGACGGCGGACGAG) and mouse 18S (5-
CGGAACTACGACGGTATCTG) were 5′ end labelled using T4 polynucleotide kinase 
(Fermentas) with 25 µCi of [γ-32P]dATP. The labelled probe was hybridized to the blot 
overnight at 50°C. The blot was then washed at 50°C twice for 20 min (5× SSC/0.1% SDS), 
followed by an additional wash (1× SSC/0.1% SDS) for 20 min. 
Northern blots were exposed to phosphorimager plates (Fuji) and scanned using a FLA-5000 
series phosphorimager (Fuji). 
 
Small RNA cloning and sequencing 
To assess the role of MCMV in the regulation of miR-27, four small RNA libraries were 
generated, either from total RNA, or from small RNAs immunoprecipitated with Ago2. For 
libraries generated from total RNA, 10 µg of total RNA was used in the initial step. For 
libraries generated from small RNAs incorporated into Ago2 containing RISC complexes, a 
fraction of the mAgo2 IPs from either MCMV infected (6 hpi), or control cells were used. 
Samples were size fractionated on a 17.5% PAGE gel, and small RNAs between 19 and 33 nt 
were excised and cloned as previously described [171], except that small RNA PCR products 
were not concatamerized, and instead sent directly for sequencing. Small RNA libraries were 
sequenced at the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC, 
Illkirch, France) using an Illumina Genome Analyzer IIx with a read length of 36 nt. 
 
Deep-sequencing data analysis 
Short sequences generated by the Illumina platform were pre-processed and annotated using 
an in-house pipeline, specifically designed to detect miRNA variants. We first applied the 
Dustmasker program [172] to filter out low complexity reads, before removing the 3′ adaptor 
from the remaining sequences using the FASTX-Toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit). Trimmed reads of 15 to 32 nt in length were then 
selected to be mapped simultaneously to the mouse (UCSC repository - assembly version 
mm9) and the MCMV (RefSeq database - accession number NC_004065.1) genomes using 
Bowtie [173] by permitting up to 1 mismatch in the first 15 read nucleotides and no limit 
beyond. Reads that could map to more than 20 loci were discarded and a post-filtering was 
applied to keep only the best alignment(s) of each small RNA sequence provided this (these) 
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alignment(s) did not exceed a total number of 9 mismatches compared to the reference 
genome. From there, all known mature and star miRNAs derived from Mus musculus and 
MCMV (miRBase v.17) were annotated by comparing their genomic coordinates to that of 
the reads, and by keeping reads with at least 50% of their length inside the genomic feature. 
By doing so, we were able to inventory and quantify all miRNA forms: full length, 3′ -
trimmed, 3′ -tailed, 5′ -trimmed, 5′ -tailed and every possible combination (5′ -trimmed+3′-
trimmed, 5′ -trimmed+3′-tailed, 5′ -tailed+3′-trimmed and 5′ -tailed+3′-tailed), may they be 
identical or different to the template sequence. During the quantification process, multiple 
mapped reads were weighted by a factor 1/n, n being the number of alignments they were 
respectively involved in. To determine the nature of the modifications affecting miR-27a and 
miR-27b upon infection, these two miRNAs were more precisely analyzed and manually 
curated to redistribute the few sequences that were mis-annotated between the two forms. 
These mis-annotations were most probably due to the poor constraints applied on the 3′ read 
ends during the mapping step. 
The data discussed in this publication have been deposited in NCBI's Gene Expression 
Omnibus and are accessible through GEO Series accession number GSE34475  
For the generation of sequence logo representations and for the comparison of libraries, 
sequencing data were normalized per million miRNA reads. In addition, only sequences that 
were cloned at least once per 1×106 miRNA reads were considered to produce Figure 
14D, Table S4 and Table S5. For Figure 14E and Figure 15, we first determined the 100 most 
abundant miRNAs in each library before selecting those that were common to all four 
libraries. We then extracted their respective tailed (only non-template additions were 
considered) and trimmed sequences, and in both cases we only kept modified miRNAs that 
were represented by at least 1 read per million miRNA reads in all four libraries. Finally, we 
calculated the sequence ratios for each selected miRNA between MCMV and mock infected 
libraries, and generated boxplot graphs. For Table S6, raw sequences of miR-27a and b prior 
to any filter were taken into account. 
 
Mice 
BALB/c (H-2d) and SCID BALB/c (H-2d) mice were housed and bred under specific-
pathogen-free conditions at the Central Animal Facility, Faculty of Medicine, University of 
Rijeka. 
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Luciferase assays 
HeLa WS cells were seeded in 48-well plates at 25,000 cells/well and then incubated for 24 h. 
Cells were then co-transfected using Lipofectamine 2000 (Invitrogen) with 25 ng of the 
reporter constructs, 250 ng of carrier pUC19 DNA and 10 nM of miRNA mimic (cel-miR-67 
as a control or miR-27a). After 24 h, cells were then washed in PBS and lysed with 65 µL of 
passive lysis buffer (Promega), and 10 µL were assayed for Firefly and Renilla luciferase 
activity, using the dual-luciferase reporter assay system (Promega) and a luminescence 
module (Glomax, Promega). The relative reporter activity was obtained by first normalizing 
to the transfection efficiency with the Renilla activity, and then, to the firefly activity obtained 
for the empty control reporter, in presence of the miR-27 mimic or control mimic, to 
normalize for the effect of transfection of these oligonucleotides. Finally, the ratios of the 
values obtained for miR-27 and control mimics were calculated. 
 
Infection conditions and detection of infectious MCMV in tissues, depletion of 
lymphocyte subsets and statistical evaluation 
Mice were injected intravenously with 1×105 PFU of tissue culture-grown wild-type MCMV 
or recombinant viruses in 0.5 mL of diluent. Organs were collected either 4 or 14 days after 
infection and virus titers were determined by a standard plaque-forming assay [174]. In 
vivo depletion of B and T cells was performed by intraperitoneal injection of the mAbs to 
CD4 (YTS191.1), to CD8 (YTS 169.4) molecules [175]. Statistical significance of the 
difference between experimental groups was determined by the Mann-Whitney exact rank 
test. 
 
Accession numbers of genes 
The following murine genes were mentioned in the text: Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; NM_008085.1), Lamin B receptor (LBR; NM_133815.2), 
Interferon regulatory factor 1 (IRF1; NM_008390.2), mmu-miR-27a (MIMAT0000537), 
mmu-miR-27b (MIMAT0000126), mmu-miR-24 (MIMAT0000219), mmu-miR-16 
(MIMAT0000527). 
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III.3 Results 
 
Degradation of miR-27a/b is mediated by a single binding site in the MCMV m169 
transcript 
Upon lytic infection with the murine cytomegalovirus (MCMV), large amounts of viral 
miRNAs are rapidly produced [58,176]. Recently, we reported that in addition to the 
expression of its own viral miRNAs, MCMV infection triggers the rapid degradation of two 
mature cellular miRNAs in various cell types, namely miR-27a and miR-27b [70]. These two 
cellular miRNAs show complete sequence identity but for the nineteenth nucleotide (“C” for 
miR-27a and “U” for miR-27b). As both miRNAs appeared to be similarly affected by 
MCMV, and because both quantitative RT-PCR (qRT-PCR) and northern blot analysis cannot 
properly distinguish miR-27a from miR-27b, we will refer indiscriminately to both miRNAs 
as miR-27. In detail, their degradation presented as a measureable decrease of the two mature 
miRNAs within 4 hours of infection, ultimately leading to an almost complete disappearance 
of miR-27 within two days of infection. Blocking viral gene expression in MCMV infected 
cells prevented miR-27 degradation [70]. It was thus tempting to speculate that this massive, 
apparently sequence-specific degradation of two cellular miRNAs was mediated by a viral 
transcript binding to the mature miRNAs, and subsequently targeting them for 
degradation via a yet to be discovered molecular mechanism. We decided to test this 
hypothesis by screening large deletion mutants to identify the gene responsible for this 
function. We started off with three MCMV mutants (Δ1,6; Δ1,7; Δ6,7) that we previously 
generated [177], each lacking two of the three gene blocks encompassing either MCMV genes 
m1–m16 (block 1), m144–m159 (block 6) or m159–m170 (block 7). It is important to note 
that none of these mutants shows any attenuation on NIH-3T3 fibroblasts in vitro, while all 
three show severe growth defects in vivo [177]. In order to ensure efficient infection of >99% 
of all cells, we always infected NIH-3T3 fibroblast with a multiplicity of infection (MOI) of 
10 for 48 h, and determined changes in miR-27 expression levels relative to miR-24 by 
quantitative RT-PCR (qRT-PCR). We chose miR-24 for normalization as it is expressed from 
the same pri-miRNA transcript as miR-27. In addition, we found qRT-PCR CT values for 
miR-24 to be virtually identical to miR-27 in uninfected cells, thus providing an ideal mean 
for normalization using the ΔΔCT -method. In accordance with our previous observations 
[70], wild-type MCMV infection resulted in a ~30-fold reduction in miR-27 levels compared 
to miR-24 (Figure 12A). While miR-27 degradation was still apparent with the Δ1,6 mutant, 
both mutants lacking gene block 7 (m159–m170) completely lost their ability to target miR-
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27 for degradation. Therefore, degradation of miR-27 indeed appeared to be mediated by a 
viral gene product. We thus generated and tested a second set of smaller deletion mutants 
(Δ7S1, Δ7S2 and Δ7S3, see Figure 12B), each lacking four MCMV genes of gene block 7. 
The results obtained with these three mutant viruses, following the same experimental setup 
as before, pinpointed the responsible viral gene to m167–m170 (Figure 12C). Finally, we 
generated and tested a third set of mutants (Δm167, Δm168, Δm169 and Δm170) lacking the 
predicted coding sequences (CDS) of the corresponding genes. Only the mutant lacking the 
predicted m168 CDS was no longer able to target miR-27 for degradation (Figure 12D). We 
thus looked for a putative binding site for miR-27 on either strand of the genome within the 
389 nt deletion of m168 using RNA-hybrid [178]. Interestingly, this revealed a single binding 
site on the strand opposite to m168, within the predicted 3′ -untranslated region (UTR) of 
m169. The binding site consists of a perfect match to the first 7 nt of miR-27a (6-mer seed 
match), a G-U pairing at the 8th position, a 5vs. 6 nt bulge (known to prevent target 
degradation via Ago2 slicer activity), and a 7 nt perfect match to the 3′ -end of the miRNA 
(including one G-U pairing adjacent to the bulge) (Figure 12E). The one nucleotide difference 
between miR-27a and miR-27b only results in a change from an A-U to a G-U pairing, which 
was predicted by RNA-hybrid to render the interaction to m169 slightly weaker for miR-27b 
than for miR-27a (mean free energy (mfe) = −23.5 kcal/mol  vs. −25.7 kcal/mol). Markerless 
mutagenesis to introduce three single point mutations into the seed region of the predicted 
binding site (MCMV-m169-mut) (marked in Figure 12E) resulted in an almost complete loss 
of miR-27 degradation from ~30-fold, down to ~2-fold (Figure 12F). Degradation of miR-27 
was completely restored for the revertant virus. However, it is important to note that only the 
middle one of these three point mutations actually disrupts seed pairing, as both A-U and G-U 
pairings are known to support RNA-RNA interactions, thus rendering the other two mutations 
less potent. Therefore, a G-U wobble at position 2, and a single mismatch in the middle of the 
seed region were sufficient to almost completely abolish miR-27 degradation. 
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Figure 12. MCMV m169 transcript is targeting miR-27 via a single binding site in its predicted 3’-UTR 
A. Gene block 7 (m149-m170) is crucial for miR-27 degradation. NIH-3T3 cells were infected with wild-type 
MCMV or three large deletion mutants each lacking two of the three gene blocks 1 (m01-m16), 6 (m144-m158) 
or 7 (m159-m170) at an MOI of 10. 48 h post infection total RNA was isolated and miR-27 levels were 
quantified relative to miR-24 by qRT-PCR. B. Genomic organization of gene block 7 and the three subdividing 
mutants. C. Degradation of miR-27 is mediated by a gene located in between m167 and m170. The effect of the 
indicated mutants on miR-27 expression was determined as described above. D. The genomic region 
encompassing the m168 coding sequence is essential for degradation of miR-27. The effect of the indicated 
mutants on miR-27 expression was determined as described above. This implicated either m168 or m169 to be 
implicated in miR-27 degradation. E. The binding site of m169 / miR-27a and miR-27b interactions. RNAhybrid 
predicted a single, well defined binding site for miR-27a/b in the predicted 3’-UTR of the m169 transcript 
showing a typical match-bulge-match structure. The three point mutations introduced by markerless mutagenesis 
to create MCMV-m169-mut are indicated. Only the middle one truly affects this interaction due to G:U  A:U 
base pairing altered by the other two. In addition, the binding site to miR-27b is shown with the single nucleotide 
difference to miR-27a indicated in bold italics. The mean free energy (mfe) of the interactions was determined 
using RNAhybrid. F. Mutagenesis of the binding site abolished miR-27 degradation. The effect of the mutant 
virus and its revertant on miR-27 levels were determined as described above. G. Expression levels of m169 and 
IE1 transcripts. NIH-3T3 fibroblasts were infected with WT MCMV at an MOI of 10. At the indicated time 
points of infection total RNA was prepared. Expression levels of m169 and IE1 were determined by qRT-PCR 
and normalized for Lamin B receptor (LBR) mRNA levels  
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To get further insights into the characteristics of the m169 transcript, we made use of data 
generated by the Jonjic and Trgovcich laboratories, which performed a large scale cDNA 
cloning and sequencing study to comprehensively characterize the MCMV transcriptome 
(Lisnic et al., manuscript in preparation). In this study, a ~1.7 kb transcript containing the 
m169 open reading frame (ORF) was identified (for transcript details see Figure 13). This 
analysis also revealed a novel intron of 78 nt, located close to the 3’-end of the putative m169 
CDS. The miR-27 binding site is located 104 nt 3’ of the m169 stop codon at the 5’ end of the 
m169 transcript 3’-UTR. Quantitative RT-PCR revealed this transcript to be already 
expressed at high levels within the first hour of infection exceeding IE1 transcripts by >2-fold 
within 4 hours of infection and >20-fold at 48 hours post infection (hpi) (Figure 12G). 
 
Figure 13. Annotated nucleotide sequence of the m169 transcript (Smith strain) 
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Degradation of miR-27 by the m169 transcript involves its 3’-tailing and -trimming 
Recently, it was reported that extensive complementarity between a target RNA and a miRNA 
can result in post-transcriptional modifications of the miRNA, mainly addition of nucleotides 
at the 3′ end of the small RNA (tailing), and shortening o f the sequence from its 3′ extremity 
(trimming) [158]. We therefore looked for post-transcriptional modifications of miR-27 at 
early times of infection prior to its degradation. We infected NIH-3T3 cells with wild-type 
MCMV at an MOI of 10 and collected cells to extract total RNA every hour from 1 to 5 hpi, 
and at 7, 9, 12, 24 and 48 hpi. We then performed high-resolution small RNA northern blot 
analysis on these RNA samples and probed for miR-27, miR-16 as well as the viral mcmv-
miR-M23-2. As can be seen on Figure 14A, miR-27 accumulated as four distinct bands in the 
mock infected cells. During the first two to three hours of MCMV infection, the pattern of 
miR-27 bands did not change, but after four hours of infection additional bands started to 
appear, while conjointly the expression level of the major band started to decrease. The 
number of extra-bands visible on the miR-27 blot culminated at 7 hpi before gradually 
decreasing again, the quantification of the most prominent band showed that miR-27 was 
almost completely degraded by 48 hpi. The level of the control miRNA miR-16 was not 
affected throughout the time course, and the accumulation of the mcmv-miR-M23-2 occurred 
as expected [58]. At the same time, we also measured the accumulation of the viral transcript 
m169 and showed that it started to become detectable by northern blot at 2 hpi, and was 
abundantly expressed at 4 hpi, coinciding with the appearance of additional bands in the miR-
27 blot (Figure 14B). 
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Figure 14. Degradation of miR-27 is linked to its 3′ -tailing and -trimming 
A. Northern blot analysis of miR-27, miR-16, miR-M23-2 in NIH-3T3 cells infected with wild type MCMV 
(MOI = 10). The arrow indicates the prominent band representing the mature miR-27, which is quantified 
relative to Mock (M) as indicated by the numbers below the blot. U6 snRNA was used as a loading control. B. 
Northern blot analysis of m169 transcript accumulation over time in the same MCMV-infected NIH-3T3 cells. 
18S rRNA was used as a loading control. C. Accumulation of miR-27a and miR-27b in Ago2 IP and total RNA 
in mock (M) and from cells infected with MCMV for 6 and 12 hours. Signals were normalized to miR-16 and 
quantified relative to mock-infected cells. D. Sequence logo representations for tailed miR-27a and 27b retrieved 
from deep-sequencing analysis of total RNA or RNA extracted after Ago2 IP of mock or MCMV-infected cells 
(6 hpi). Only nucleotides 15 to 27 of miR-27 sequences presenting 3′ addition are represented, nucleotides of 
interest are depicted in colour, and the sizes of the largest tails are indicated next to the arrows. The genomic 
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sequences of pre-miR-27a and b are indicated underneath the sequence logo representations. E. Boxplot 
representation of the trimmed and tailed MCMV/mock sequence ratios for the most abundant miRNAs shared by 
each library. Only sequences presenting with a 3′ -trimming or a -tailing of ≥3 nt in total RNA or RNA extracted 
after Ago2 IP were considered. The outliers are indicated by black dots and miR-27a and b are indicated by a 
blue square and an orange triangle respectively. The green dot indicates sequences that could not be annotated as 
either miR-27a or 27b due to their trimming. The black bar indicates the median of all ratios. 
 
In order to gain further insight into the level at which the degradation of miR-27 occurs, we 
then performed Ago2 immunoprecipitation (IP) of NIH-3T3 cells infected with MCMV at 6 
and 12 hpi. We analyzed the accumulation of miR-27 in both the total RNA and RNA isolated 
after Ago2 IP. Although the resolution of this gel was not as good as in the previous northern 
blot, we could still see some tailing of miR-27 in the total RNA at 6 and 12 hpi (Figure 14C). 
Interestingly, the extent of tailing seemed to be lower in the RNA isolated from the Ago2 IP. 
In addition, miR-27 levels decreased significantly more rapidly in the Ago2 IP than in total 
RNA (Figure 14C), indicating that tailing of miR-27 might be accompanied by its 
displacement from Ago2 complexes subsequently followed by its degradation, or that 
extensive tailing occurred after displacement of miR-27 from Ago2. 
We then set up to determine the nature of the modification of miR-27a and miR-27b by 
performing small RNA cloning and Illumina deep-sequencing using either total RNA 
extracted from mock-infected NIH-3T3 cells, or from cells infected with MCMV for 6 hours, 
as well as from RNA extracted after Ago2 IP from the same samples. The analysis of miR-
27a and miR-27b sequences in the libraries revealed that in both mock- and MCMV-infected 
cells, addition of non-templated nucleotides could be detected at the 3′ end, consistent with 
the northern blot data. Therefore, the additional bands seen for miR-27 by northern blot 
represent 3′-tailing with non-templated nucleotides, rather than processing isoforms. 
However, it is important to note that this feature was not unique to miR-27, but also seen for 
other cellular miRNAs. As can be seen in a sequence logo representation [179,180] of cloned 
miR-27a and b in total RNA extracted from MCMV-infected cells, the number of added 
nucleotides was greater for miR-27a (up to 3 nt in the mock vs. 7nt in the infected cells) than 
miR-27b (2 nt in mock vs. 4 nt MCMV infected cells respectively) (Figure 14D). The number 
of sequences presenting with longer tails, however, was lower for miR-27a than for miR-27b 
(Tables S4 and S5). The most prominent nucleotide added was an ‘A’, followed by a ‘U’.  
Intriguingly, in Ago2 IP the difference in tailing between mock and MCMV infected cells 
was neither evident for miR-27a nor miR-27b, indicative of displacement of extensively tailed 
miRNAs from Ago2, or conversely, tailing of miRNAs after displacement from Ago2. To 
estimate the significance of the modifications of miR-27 in MCMV infected cells, we 
extracted (for the most abundantly cloned cellular miRNAs) the number of sequences 
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presenting with a tail of ≥3 nt, and calculated the ratio of these values betwe en MCMV and 
mock infected cells. Given that miRNA tailing has been associated with their trimming, we 
also performed the same analysis for sequences trimmed by at least 3 nt. We found that, in 
total RNA, miR-27b was significantly more tailed in MCMV infected cells compared to mock 
infected cells (4.35-fold) than any other cellular miRNA (median of ratio = 1.59) (Figure 
14E). The ratio for miR-27a was 2.00, which is above the mean, but still inside the 
interquartile range. In addition, the enrichment of tailed miR-27b in MCMV infected cells 
was lost in Ago2 IP (Figure 14E). Only one other cellular miRNA, namely miR-21, showed 
significantly enhanced 3′ tailing in MCMV infected cells ( Figure 14E). As for miR-27b, this 
was only seen in total RNA but not in the Ago2 IP. Regarding the trimmed miRNAs, a strong 
enrichment (17.64-fold vs. a median ratio of 2.63) in MCMV infected cells compared to mock 
infected cells could be seen for miR-27 (due to the trimming, these sequences could not be 
attributed to either miR-27a or b). As for the tailed sequences, this enrichment was lost in the 
Ago2 IP. Only one other outlier, namely miR-434, showed an increased trimming in total 
RNA of MCMV vs. mock infected cells. Interestingly, this miRNA was also observed to be 
down-regulated in MCMV-infected cells (data not shown). We were unable to resolve 
trimming of miR-27 by northern blot. Finally, we also looked at miRNAs tailed or trimmed 
with ≥1 nt ( Figure 15A), or ≥2 nt ( Figure 15B), but did not find a significant difference 
between MCMV infected cells and non-infected cells for miR-27a and b. This is most 
probably due to the fact that both miRNAs already show the addition of up to 2 nucleotides in 
mock-infected cells, thereby introducing substantial variability and thus noise to our analysis. 
A global overview of all modifications observed for miR-27a and b can be found in Table S6. 
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Figure 15. Boxplot representations of the trimmed and tailed MCMV/mock sequence ratios for the most 
abundant miRNAs common to all libraries 
Only sequences trimmed or tailed by ≥1 nt (A) or ≥2 nt (B) in total RNA or RNA extracted after Ago2 IP were 
considered. The outliers are indicated by black dots and miR-27a and b are indicated by a blue square and an 
orange triangle, respectively. The black bar indicates the median of all ratios. 
 
III       Degradation of cellular miR-27 by a novel, highly abundant                                                              Results 
            viral transcript is important for efficient virus replication in vivo  
 67 
Retargeting of m169 to other cellular and viral miRNAs by target site replacement 
In order to further characterize the mechanism of miR-27 degradation and obtain useful tools 
for further studies, we next tested whether we could retarget m169 to other cellular or viral 
miRNAs. We thus replaced the m169 binding site for miR-27 with a binding site for the 
ubiquitous cellular miR-16, or for the highly abundant viral miRNA mcmv-miR-M23-2 
(Figure 16A). Binding sites were designed to mimic the natural match-bulge-match structure 
of the miR-27a binding site. We chose mcmv-miR-M23-2 as we recently found this miRNA 
(together with mcmv-miR-21-1) to be required for viral persistence in salivary glands [61]. 
After generating the mutant viruses (MCMV-m169-miR-16 and MCMV-m169-miR-M23-2) 
we performed a time-course of infection in NIH-3T3 cells with these viruses and performed 
northern blot analysis to probe for the effect of their retargeting on miR-27, miR-16 and 
mcmv-miR-M23-2 levels (Figure 16B). As expected, retargeting of m169 to other miRNAs 
by altering the miR-27 binding site completely abolished the ability of both mutants to 
mediate miR-27 degradation. In contrast, the MCMV-m169-mut still showed a slight 
reduction of miR-27 levels consistent with the ~2-fold reduction in miR-27 levels observed 
by qRT-PCR (see Figure 12F). Apparently, the single G-C to A-C change and the two 
 A-U↔G-U changes to the seed region of the m169 binding site were not sufficient to 
completely abolish miR-27 binding. Most interestingly, this was accompanied by enhanced 
tailing of miR-27, represented by the appearance of additional bands on the northern blot. In 
contrast, complete disruption of this binding site by retargeting it to either miR-16 or mcmv-
miR-M23-2 did not show this phenomenon. Together with the sequencing data shown 
in Figure 14D, these data provide strong evidence that miR-27 binding at this site mediates its 
tailing, either directly, or by displacing it from its Argonaute protein. 
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Figure 16. Retargeting of m169 to cellular and viral miRNAs 
A. Schematic representation of the miR-27a/m169 binding site and the introduced mutated binding sites 
resulting in retargeting of m169 to either mmu-miR-16 or mcmv-miR-M23-2. Target site predictions were 
performed using RNAhybrid to design the retargeting of m169. B. Efficient retargeting of m169 to a cellular and 
a viral miRNA. NIH-3T3 cells were infected with the indicated viruses and total RNA isolated at different times 
of infection was analyzed by northern blot for miR-27, miR-16 and mcmv-miR-M23-2. U6 served as loading 
control. Retargeting of m169 to miR-16 and mcmv-miR-M23-2 abolished degradation of miR-27 but resulted in 
highly efficient degradation of the respective miRNAs. C. Expression of m169 3′ -UTR is sufficient to mediate 
miR-27 degradation. Adenoviral vectors expressing either full-length m169 or its 3′ -UTR fused to EGFP were 
used to transduce NIH-3T3 cells at an MOI of either 50 or 500. An adenoviral vector expressing mCherry was 
used as negative control. Two days post-transduction, total RNA was prepared and miR-24/miR-27 ratios were 
determined by qRT-PCR. 
 
Infection with MCMV-m169-miR-16 resulted in the rapid degradation of miR-16 within the 
first four hours of infection. In addition, infection with MCMV-m169-miR-M23-2 completely 
abolished any detectable signal for mcmv-miR-M23-2 despite its strong expression and 
continuous accumulation during lytic MCMV infection (Figure 14B). Therefore, target site 
replacement of this single miRNA binding site in m169 is sufficient to efficiently target both 
cellular and viral miRNAs for rapid degradation. 
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Expression of m169 transcript alone is sufficient to target miR-27 for degradation 
To test whether any other viral factors were involved in miR-27 degradation, we generated 
replication-deficient adenoviral vectors expressing either full-length m169 or its 3′-UTR fused 
to EGFP controlled by an EF1 promoter. An adenoviral vector expressing mCherry served as 
negative control. NIH-3T3 cells were transduced using an MOI of 50 or 500 (virus titers 
determined using HEK-293 cells) in the presence of TransMAX reagent to enhance 
transduction efficiency. Forty-eight hours after transduction of NIH-3T3 cells with these four 
adenoviruses, miR-27, miR-24 and m169 transcript levels were determined by qRT-PCR. 
Interestingly, expression of the 3′ -UTR of m169 fused to EGFP was sufficient to mediate an 
MOI-dependent ~6-fold loss of miR-27 levels (Figure 16C). This is in accordance with m169 
transcript levels being the highest in this condition but still 5- to 10-fold lower than those 
achieved by lytic MCMV infection as determined by qRT-PCR (data not shown). Therefore, 
expression of the 3′ -UTR of m169 fused to a protein coding gene is sufficient to target a 
cellular miRNA for degradation and no other viral factors appear to be essential to this 
process. 
As the 3′ -UTR of m169 was apparently sufficient to mediate degradation of miR-27, we 
looked for additional motifs in it. We noticed a uridine-rich stretch located 69 nt 3′ of the 
miR-27 binding site. Using markerless mutagenesis we mutated this stretch from 
‘UUUUUGUUUUUU’ to ‘AAGAAGAAAGAA’ in the MCMV genome and reconstituted 
the mutant virus. However, this did not alleviate degradation of miR-27 following high MOI 
infection of NIH-3T3 fibroblasts (Figure 17). 
 
 
 
III       Degradation of cellular miR-27 by a novel, highly abundant                                                              Results 
            viral transcript is important for efficient virus replication in vivo  
 70 
 
Figure 17. Mutagenesis of the pyrimidine-rich stretch close to the miR-27 binding site has no significant 
effect on miR-27 degradation 
To generate MCMV-m169-URS-mut, the pyrimidine-rich stretch located 69 nt 3′ of the miR-27 binding site was 
mutated from ‘TTTTTGTTTTTT’ to ‘AAGAAGAAAGAA’ using markerless mutagenesis. The primers used to 
amplify the Kanamycin resistance gene encoded on the plasmid pEPKAN-S are included in Table 2. Following 
virus reconstitution, NIH-3T3 cells were infected with mock, m169-URS-mut or wild-type MCMV (WT) at an 
MOI of 10. At 48 hpi miR-24 and miR-27 levels were determined by q-RT-PCR. No significant difference in 
miR-27 degradation between m169-URS-mut and wild-type MCMV infection was observed. 
 
m169 is a target of miR-27 
While the m169 transcript obviously has a detrimental impact on miR-27 or any other miRNA 
binding to it in a miR-27-like manner, we needed to consider the option that the virus might 
simply utilize an abundant cellular miRNA to regulate expression of one of its genes. We thus 
investigated the effect of miR-27 on m169 RNA levels. First, we looked at m169 RNA levels 
following infection with wild-type MCMV, MCMV-m169-mut, its revertant, as well as the 
retargeted mutant MCMV-m169-miR-16. Expression levels of m169 mRNA at 24 and 48 hpi 
were determined relative to IE1 mRNA levels (to normalize for differences in infection) using 
qRT-PCR. The level of m169 mRNA was significantly greater (~2-fold, p<0.001) for 
MCMV-m169-mut than for the other three viruses (Figure 18A). This is consistent with a 
partial loss of regulation of m169-mut by miR-27 (resulting in increased m169 levels) and an 
efficient retargeting of m169 by miR-16 which we found to be expressed at very similar 
levels as miR-27 using qRT-PCR (data not shown). At 48 hpi no differences in m169 
transcript levels were observed anymore. 
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Figure 18. m169 is a target of miR-27. 
A. Effect on m169 RNA levels. To assess the effect of the miRNA/m169 interaction on m169 transcript levels, 
NIH-3T3 cells were infected with wild-type MCMV, MCMV-m169-mut, its revertant as well as the retargeted 
mutant MCMV-m169-miR-16. At 24 and 48 hpi total RNA was prepared and m169 transcript levels were 
determined by qRT-PCR. In parallel IE1 RNA levels were quantified to normalize for dose of infection. 
Disruption of the miR-27 binding site (MCMV-m169-mut) resulted in significantly increased (One-way anova 
analysis followed by Tukey's multiple comparisons test: ***: p<0.0001) m169 transcript levels at 24 hpi. This 
was restored when m169 was retargeted to miR-16 and no longer seen at 48 hpi. B. Dual-luciferase assay with 
psiCHECK2 constructs containing either no UTR, a perfect match (PM) binding site for miR-27, the wild type 
or the point mutant version of the m169 3′UTR. HeLa WS cells were co -transfected with the luciferase construct 
and a control miRNA mimic, or a miR-27a mimic. The ratios of normalized luciferase values for miR-27 and 
control mimics are indicated. ** p<0.001. 
 
We next assessed whether a luciferase sensor containing the m169 3′ -UTR could be regulated 
by miR-27. We therefore generated pSI-CHECK2 plasmids containing either a perfect match 
to miR-27, the full-length m169 3′UTR, or the point mutant version of the 3′ UTR that was 
used in the virus infection experiment. These constructs were co-transfected into HeLa cells 
with control or miR-27 miRNA mimics (to prevent any possible down-regulation of the 
miRNA by these targets). As can be seen in Figure 18B, the perfect match sensor for miR-27 
was 80% down-regulated by miR-27, while the m169 3′ -UTR reporter showed a 60% down-
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regulation. The insertion of the three point mutations in the m169 3′ -UTR only partially 
alleviated its regulation by miR-27 to about 40%, which is consistent with the 2-fold effect of 
the respective mutant virus on miR-27 levels at 48 hpi. This indicates that the m169-mut 
transcript can no longer efficiently mediate miR-27 degradation, but is still partially regulated 
by miR-27. In summary, these data indicate a complex mutual interaction between miR-27 
and m169. 
 
The reciprocal interaction between miR-27 and m169 is important for in vivo infection 
As the interaction between the m169 transcript and miR-27a appears to be mutual, the key 
question was whether the virus uses the m169 transcript to target an important cellular 
miRNA for degradation, or whether it simply uses an irrelevant but highly expressed cellular 
miRNA to reduce and delay protein expression of one of its genes. To address this question, 
we made use of our mutant and retargeted viruses and studied their phenotypes following 14 
days of infection in mice. While we designed the three point mutations in MCMV-m169-mut 
such as not to alter the predicted m168 coding sequence, it is important to note that this was 
not possible for both MCMV-m169-miR-16 and MCMV-m169-miR-M23-2. For MCMV-
m169-miR-M23-2 this altered six amino acids in m168. For MCMV-m169-miR-16 this 
resulted in a frame-shift and a premature stop codon 28 amino acids later (for details 
see Table 4). So far nothing is known about the function of m168, or whether it is expressed 
at all. However, we failed to detect any expression of the m168 transcript even at late time-
points (both 24 and 48 hpi) of lytic MCMV infection of NIH-3T3 fibroblasts using next-
generation sequencing (unpublished data). We thus infected BALB/c mice for 14 days with 
these viruses and determined virus titers in lungs. Interestingly, we observed a significant 3- 
to 12-fold attenuation of all three viruses, the greatest attenuation being observed for the 
m169-mut virus; no attenuation was observed for the revertant virus MCMV-m169-mut-rev 
(Figure 19A). This was also seen in BALB/c mice depleted for both CD4+ and CD8+ T-cells, 
indicating that the observed attenuation was independent of T-cell function. Next, we infected 
SCID BALB/c mice with wild-type MCMV, MCMV-m169-mut, or its revertant. At 14 days 
post infection (dpi) we again observed significant (~10-fold) attenuation of this mutant virus 
in both lungs and salivary glands (Figure 19B). We conclude that the quite striking role of 
miR-27 during lytic MCMV infection is independent of adaptive immunity. To test whether 
this phenotype would become apparent even at earlier stages of acute infection, we infected 
BALB/c mice for four days and compared virus titers in lung and spleen. While virus titers in 
lungs showed only a moderate, but consistent reduction in virus titers for all three mutants no 
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longer targeting miR-27, a strong 10- to 100-fold attenuation of all three mutants was 
observed in spleen (Figure 19C). Altogether, these data highlight that degradation of miR-27 
by the MCMV m169 transcript, and presumably also the miRNA-mediated regulation of 
m169 protein expression are important factors during lytic virus infection in vivo. 
 
Table 4.  Changes in nucleotide sequence of the different mutants and their impact on the putative m168 
coding sequence 
WT-MCMV           
ggg act tct ttt cac agc tta tta ttc cgc aga tcg tcg tct   
G    T      S    F    H    S     L     L    F    R   R     S    S   S 
 
  
  
    
  
MCMV-m169-mut 
   
  
ggg act tct ttc cat agt tta tta ttc cgc aga tcg tcg tct   
G     T     S    F   H    S    L     L     F    R    R     S    S   S 
 
  
  
    
  
MCMV-m169-mut-rev 
   
  
ggg act tct ttt cac agc tta tta ttc cgc aga tcg tcg tct   
G    T      S    F    H    S     L     L    F    R    R     S   S   S 
 
  
  
    
  
MCMV-m169-miR-16 
   
  
=> G    T   S    and then a frameshift and stop codon after about 28 
aminoacids 
  
    
  
MCMV-m169-miR-M23-2 
   
  
ggg act ctt tat ggg ggc gtt tac aag cgg aga tcg tcg tct   
  G   T     S    Y     G    G    V    Y    K    R      R     S    S     S   
 
III       Degradation of cellular miR-27 by a novel, highly abundant                                                              Results 
            viral transcript is important for efficient virus replication in vivo  
 74 
 
Figure 19. Degradation of miR-27 is important for efficient virus replication in vivo. 
BALB/c (A) or SCID BALB/c (B) mice were injected intravenously (i.v.) with 1×105PFU of wild-type (wt), 
MCMV-m169-mut, m169-mut-rev or the two retargeted viruses MCMV-m169-miR-16 and –miR-M23-2. Some 
of the BALB/c mice were depleted of CD4 and CD8 T cells. At 14 dpi organs were harvested and virus titers in 
lungs and salivary glands determined by standard plaque assay. C. BALB/c mice were injected i.v. with 
1×105 PFU of indicated viruses. At 4 dpi organs were harvested and virus titers in lungs and spleen determined 
by standard plaque assay. Viral titers in organs of individual mice (circles) and median values (horizontal bars) 
are shown. DL = detection limit; * p<0.05; ** p<0.01. 
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III.4 Discussion 
 
Besides expressing large amounts of viral miRNAs shortly after infection [58], MCMV also 
targets two cellular miRNAs for rapid degradation, namely miR-27a and b [70]. Using a set of 
deletion mutants and site directed mutagenesis, we show this effect to be mediated by a single 
binding site located within the 3′ -UTR of a so far uncharacterized, highly abundant, spliced 
MCMV transcript, namely m169. We found this effect to be readily redirected to other 
cellular and viral miRNAs by target site replacement. Interestingly, expression of the m169 
3′-UTR fused to EGFP by an adenoviral vector was sufficient to mediate degradation of miR-
27, indicating that no other viral factors are essentially required in this process. 
Recently, Ameres et al. reported on tailing and trimming of cellular miRNAs upon extensive 
base-pairing to their targets [158]. However, the underlying mechanism still remains to be 
determined. Thus, it is not known whether this is happening to miRNAs still bound by an 
Argonaute protein, or after their displacement from RISC. Upon wild-type MCMV infection, 
we observed extensive tailing of miR-27 by northern blot within the first few hours of 
infection, prior to its subsequent degradation. The tailing and degradation of miR-27 was not 
observed in cells infected with mutant viruses in which the miR-27/m169 RNA interaction 
was disrupted by retargeting m169 to either miR-16 or mcmv-miR-M23-2. This argues 
against a general effect of MCMV infection on miR-27 tailing. Despite the point mutations 
we introduced into the miR-27 binding site to generate MCMV-m169-mut, the m169-mut 
transcript was still able to bind miR-27, demonstrated by significant miR-27-mediated 
repression in dual-luciferase assays. In addition, it still resulted in a somewhat reduced but 
significant activity for miR-27 degradation (~2-fold instead of ~30-fold) as observed by both 
qRT-PCR and northern blot. Interestingly, we observed enhanced tailing of miR-27 following 
infection with MCMV-m169-mut compared to wild-type MCMV infection. Most likely, this 
is due to the larger amounts of miR-27 still present at 6–24 hpi. While these data thus provide 
strong hints that binding of miR-27 to this single binding site not only triggers its degradation 
but also its tailing, further studies are required to clarify the link between the two. 
Consistent with the northern blot data, small RNA deep-sequencing revealed 3′ -tailing with 1 
to 3 non-template nucleotides for both miR-27a and miR-27b in uninfected cells. The 
presence of non-template tailing is a common feature of miRNAs, indicating that this is not 
unique to miR-27a/b. This was seen in both total RNA as well as Ago2 IP samples 
independent of MCMV infection. Upon MCMV infection, however, we observed both an 
enhanced tailing of miR-27b, as well as trimming of miR-27 (≥3nt) in small RNA libraries 
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prepared from total RNA. Interestingly, this increased tailing and trimming of miR-27 was 
not detectable in small RNA isolated from Ago2 IP samples, which might indicate that these 
modifications occur after m169-mediated displacement of miR-27 from Ago2, or that the 
tailed and trimmed miR-27 forms are rapidly excluded from it. This is partially corroborated 
by the northern blot analysis, which showed a stronger MCMV-mediated down-regulation of 
miR-27 in Ago2 than in total RNA. The observation that miR-27b, and not miR-27a, showed 
enhanced tailing might be due to its slightly weaker interaction with m169, because a Watson-
Crick base pair with the m169 transcript is replaced by a G-U pairing. It is thus tempting to 
speculate that we simply might have cloned and sequenced more tailed miR-27b in MCMV 
infected cells because it is less efficiently degraded than miR-27a – thereby either leaving less 
time for tailing of miR-27a following displacement from Ago2, or speeding up displacement 
of tailed miR-27a from Ago2 followed by its more rapid degradation. This would also explain 
the more rapid loss of both miR-16 and mcmv-miR-M23-2 following infection with the 
retargeted mutants, rendering tailing of these miRNAs below the detection limit of our 
northern blots. Studies are ongoing to address this important issue. 
In a previous study [58], we already reported on extensive tailing of two viral miRNAs, 
namely mcmv-miR-m21-1 and mcmv-miR-M23-2, which was accompanied by a decrease of 
these miRNAs late in infection. As we found these two miRNAs to derive from a genomic 
locus transcribed from both the sense and antisense strand, tailing and degradation of these 
two miRNAs might result from binding to viral transcripts expressed from the antisense 
strand. Together with the data presented in this study, we therefore postulate that highly 
expressed transcripts, such as MCMV m169, can cause miRNA tailing (and trimming) 
followed by their degradation. 
As m169 targets Argonaute-bound miR-27 for degradation, it was very reasonable to assume 
that m169 may also serve as a target for miR-27. Indeed we observed significantly higher 
m169 RNA levels following infection with MCMV-m169-mut than for wild-type MCMV, its 
revertant, or MCMV-m169-miR-16. Interestingly, this was only observed at 24 hpi, which 
was verified in three independent experiments. In contrast, at 48 hpi when wild-type MCMV 
infection has efficiently eliminated miR-27, its effect on m169 expression was relieved. As 
such, the mutual interaction between the m169 transcript and miR-27 is apparently complex. 
The key question really was whether the main function of m169 is to target an important 
cellular miRNA for degradation, or whether the virus simply uses an irrelevant but highly 
expressed cellular miRNA to reduce and delay protein expression of one of its genes. With 
the help of our retargeted viruses we were able to partially address this important question. 
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Interestingly, all three mutant viruses no longer able to efficiently target miR-27 for 
degradation were significantly attenuated at 4 and 14 dpi in all experiments we performed. 
This was particularly prominent in both spleen at 4 dpi, and in lungs at 14 dpi. It is, however, 
important to note that the generation of both MCMV-m169-miR-16 and MCMV-m169-miR-
M23-2 (but not MCMV-m169-mut) resulted in alterations to the predicted m168 coding 
sequence. While we were unable to detect m168 expression by next-generation sequencing 
even at late times of infection (unpublished data; data not shown) this does not rule out that 
alterations in m168 may have contributed to the observed phenotype. In addition, we cannot 
exclude that degradation of miR-16 by MCMV-m169-miR-16 may have contributed to this 
phenotype. In contrast, we recently provided an extensive set of data showing that knock-out 
of mcmv-miR-M23-2 has no apparent effect on lytic virus replication in various organs at 4 
dpi and in lungs at 14 dpi [61]. The knock-out (which also includes the knock-out of mcmv-
miR-m21-1 which is generated from the antisense strand) only resulted in significantly lower 
virus titers in salivary gland at 14 dpi. In the course of the current study we decided to 
generate MCMV-m169-miR-M23-2 hoping to be able to further dissect the phenotype of the 
miR-m21-1/-M23-2 double miRNA knock-out virus in salivary gland [61]. However, as all 
three viruses no longer able to efficiently target miR-27 for degradation also showed 
significant attenuation in salivary gland at 14 dpi, this aim could not be achieved. In 
conclusion, it may thus well be that other factors than degradation of miR-27 contributed to 
the attenuation of the different mutants we observed. In particular the role of miR-27 in 
controlling the timing of m169 expression requires further studies. This and other factors are 
likely to have contributed to the attenuation of our three mutant viruses. However, as all three 
mutants deficient for miR-27 degradation were attenuated in vivo we believe this provides 
good evidence that degradation of miR-27 is indeed important during acute MCMV 
infection in vivo. 
So far little is known about the function of miR-27. Our data provide strong evidence that 
miR-27 expression is harmful to productive MCMV infection. Interestingly, the Steitz 
laboratory recently showed that the oncogenic herpesvirus saimiri also uses one of its non-
coding RNAs to target miR-27 for degradation [71]. This supports the interpretation of our 
data that degradation of miR-27 is indeed of importance for MCMV, and probably also for 
herpesvirus saimiri. The mechanism by which degradation of miR-27 aids lytic MCMV 
infection still remains elusive. To date, these two miRNAs have been implicated in pathways 
such as cell differentiation [181], adipogenesis [182], and angiogenesis [183]. Among the 
validated cellular targets, the tumor suppressor FOXO1, which is involved in controlling the 
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cell cycle through CDKN1C induction [184], might provide a link to the strong phenotype we 
observed during acute MCMV infection. Indeed, cytomegaloviruses are known for their 
manipulation of the cell cycle [185], and m169 may act by releasing the effects of miR-27 on 
cell cycle progression. Interestingly, recent reports showed that the level of the miR-16 family 
of miRNAs are efficiently destabilized in response to cell-cycle changes [186]. Therefore, 
rapid alterations in cellular miRNAs are likely to be of importance in the regulation of cell 
cycle progression. 
Why does m169 so efficiently target miR-27 for degradation? We noted m169 to be expressed 
at extremely high levels within 4 h of infection, exceeding levels of IE1 by >20-fold at 24 h 
post infection. The number of m169 transcripts obviously matters. Mutagenesis of a uridine-
rich motif, which we observed in close proximity to the miR-27 binding site, had no effect on 
miR-27 degradation. The shift from a classical miRNA-target interaction, where the miRNA 
regulates its target, and the opposite effect, i.e. miRNA degradation mediated by its RNA 
target, might thus simply be controlled by the relative abundance of the target RNA. When 
the m169 transcript reaches a certain level, it may thus start to trigger degradation of miR-27, 
ultimately avoiding its regulatory effect. Further studies are required to address this 
interesting question. 
In conclusion, there is now increasing evidence that the expression of miRNAs is strongly 
regulated, and that these molecules are not as stable as they were once thought to be. They are 
part of a sophistically tuned, complex reciprocal interaction network with the mRNA targets 
they regulate. The ability of cytomegalovirus to usurp the underlying cellular machinery by 
expressing decoy targets which bind to specific miRNAs and degrade them is yet another 
illustration of the fascinating dynamism of RNA-mediated regulation. 
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